Neuro-urology

4. REFERENCES

1.Schafer, W., et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn, 2002. 21: 261. 
https://www.ncbi.nlm.nih.gov/pubmed/11948720

2.Abrams, P., et al. Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn, 2009. 28: 287. 
https://www.ncbi.nlm.nih.gov/pubmed/19350662

3.Abrams, P., et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn, 2002. 21: 167. 
https://www.ncbi.nlm.nih.gov/pubmed/11857671

4.Groen, J., et al. Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. Eur Urol, 2016. 69: 324. 
https://www.ncbi.nlm.nih.gov/pubmed/26304502

5.Nosseir, M., et al. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn, 2007. 26: 228. 
https://www.ncbi.nlm.nih.gov/pubmed/16998859

6.Panicker, J.N., et al. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol, 2015. 14: 720. 
https://www.ncbi.nlm.nih.gov/pubmed/26067125

7.Phillips, B., et al. Oxford Centre for Evidence-based Medicine Levels of Evidence. Updated by Jeremy Howick March 2009. 1998. 
https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009

8.Guyatt, G.H., et al. Going from evidence to recommendations. BMJ, 2008. 336: 1049. 
https://www.ncbi.nlm.nih.gov/pubmed/18467413

9.Townsend, N., et al. Cardiovascular disease in Europe--epidemiological update 2015. Eur Heart J, 2015. 36: 2696. 
https://www.ncbi.nlm.nih.gov/pubmed/26306399

10.Tibaek, S., et al. Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey. Neurourol Urodyn, 2008. 27: 763. 
https://www.ncbi.nlm.nih.gov/pubmed/18551565

11.Funayama, M., et al. Post-stroke urinary incontinence is associated with behavior control deficits and overactive bladder. Neuropsychologia, 2024. 201: 108942. 
https://www.ncbi.nlm.nih.gov/pubmed/38906459

12.Marinkovic, S.P., et al. Voiding and sexual dysfunction after cerebrovascular accidents. J Urol, 2001. 165: 359. 
https://www.ncbi.nlm.nih.gov/pubmed/11176374

13.Yamashita, K., et al. An Evaluation of the Postvoid Residual Urine Volume in Acute Stroke Patients. Res Rep Urol, 2024. 16: 265. 
https://www.ncbi.nlm.nih.gov/pubmed/39430409

14.Rotar, M., et al. Stroke patients who regain urinary continence in the first week after acute first-ever stroke have better prognosis than patients with persistent lower urinary tract dysfunction. Neurourol Urodyn, 2011. 30: 1315. 
https://www.ncbi.nlm.nih.gov/pubmed/21488096

15.Chiu, T.-H., et al. Risk factors for urinary retention requiring catheterization after ischemic middle cerebral artery stroke. Urological Science, 2024. 35: 134. 
http://www.e-urol-sci.com/

16.Lobo, A., et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology, 2000. 54: S4. 
https://www.ncbi.nlm.nih.gov/pubmed/10854354

17.Na, H.R., et al. Urinary incontinence in Alzheimer’s disease is associated with Clinical Dementia Rating-Sum of Boxes and Barthel Activities of Daily Living. Asia Pac Psychiatry, 2015. 7: 113. 
https://www.ncbi.nlm.nih.gov/pubmed/23857871

18.Grant, R.L., et al. First diagnosis and management of incontinence in older people with and without dementia in primary care: a cohort study using The Health Improvement Network primary care database. PLoS Med, 2013. 10: e1001505. 
https://www.ncbi.nlm.nih.gov/pubmed/24015113

19.Pringsheim, T., et al. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord, 2014. 29: 1583. 
https://www.ncbi.nlm.nih.gov/pubmed/24976103

20.Picillo, M., et al. The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson’s disease. Eur J Neurol, 2017. 24: 788. 
https://www.ncbi.nlm.nih.gov/pubmed/28425642

21.Kim, M.S., et al. Urodynamic study and its correlation with cardiac meta-iodobenzylguanidine (MIBG) in body-first and brain-first subtypes of Parkinson’s disease. Eur J Neurol, 2024. 31: e16497. 
https://www.ncbi.nlm.nih.gov/pubmed/39345023

22.Li, F.F., et al. Prevalence of lower urinary tract symptoms, urinary incontinence and retention in Parkinson’s disease: A systematic review and meta-analysis. Front Aging Neurosci, 2022. 14: 977572. 
https://www.ncbi.nlm.nih.gov/pubmed/36172485

23.Papatsoris, A.G., et al. Urinary and erectile dysfunction in multiple system atrophy (MSA). Neurourol Urodyn, 2008. 27: 22. 
https://www.ncbi.nlm.nih.gov/pubmed/17563111

24.Kim, M., et al. Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson’s disease. Parkinsonism Relat Disord, 2015. 21: 205. 
https://www.ncbi.nlm.nih.gov/pubmed/25534084

25.Sakakibara, R., et al. A guideline for the management of bladder dysfunction in Parkinson’s disease and other gait disorders. Neurourol Urodyn, 2016. 35: 551. 
https://www.ncbi.nlm.nih.gov/pubmed/25810035

26.Yamamoto, T., et al. Postvoid residual predicts the diagnosis of multiple system atrophy in Parkinsonian syndrome. J Neurol Sci, 2017. 381: 230. 
https://www.ncbi.nlm.nih.gov/pubmed/28991688

27.Vichayanrat, E., et al. Pelvic autonomic dysfunction is common in patients with pure autonomic failure. Eur J Neurol, 2024. 31: e16486. 
https://www.ncbi.nlm.nih.gov/pubmed/39344662

28.Dolecek, T.A., et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol, 2012. 14 Suppl 5: v1. 
https://www.ncbi.nlm.nih.gov/pubmed/23095881

29.Maurice-Williams, R.S. Micturition symptoms in frontal tumours. J Neurol Neurosurg Psychiatry, 1974. 37: 431. 
https://www.ncbi.nlm.nih.gov/pubmed/4365244

30.Christensen, D., et al. Prevalence of cerebral palsy, co-occurring autism spectrum disorders, and motor functioning - Autism and Developmental Disabilities Monitoring Network, USA, 2008. Dev Med Child Neurol, 2014. 56: 59. 
https://www.ncbi.nlm.nih.gov/pubmed/24117446

31.Samijn, B., et al. Lower urinary tract symptoms and urodynamic findings in children and adults with cerebral palsy: A systematic review. Neurourol Urodyn, 2017. 36: 541. 
https://www.ncbi.nlm.nih.gov/pubmed/26894322

32.Ryan, J.M., et al. Prevalence and incidence of chronic conditions among adults with cerebral palsy: A systematic review and meta-analysis. Dev Med Child Neurol, 2023. 65: 1174. 
https://www.ncbi.nlm.nih.gov/pubmed/36807150

33.Tagliaferri, F., et al. A systematic review of brain injury epidemiology in Europe. Acta Neurochir (Wien), 2006. 148: 255. 
https://www.ncbi.nlm.nih.gov/pubmed/16311842

34.Kulakli, F., et al. Relationship between urinary dysfunction and clinical factors in patients with traumatic brain injury. Brain Inj, 2014. 28: 323. 
https://www.ncbi.nlm.nih.gov/pubmed/24377376

35.Aruga, S., et al. Effect of cerebrospinal fluid shunt surgery on lower urinary tract dysfunction in idiopathic normal pressure hydrocephalus. Neurourol Urodyn, 2018. 37: 1053. 
https://www.ncbi.nlm.nih.gov/pubmed/28892272

36.Singh, A., et al. Global prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol, 2014. 6: 309. 
https://www.ncbi.nlm.nih.gov/pubmed/25278785

37.Weld, K.J., et al. Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Urology, 2000. 55: 490. 
https://www.ncbi.nlm.nih.gov/pubmed/10736489

38.El Sammak, S., et al. Prediction Model for Neurogenic Bladder Recovery One Year After Traumatic Spinal Cord Injury. World Neurosurg, 2023. 179: e222. 
https://www.ncbi.nlm.nih.gov/pubmed/37611802

39.Pavese, C., et al. Prediction of Bladder Outcomes after Traumatic Spinal Cord Injury: A Longitudinal Cohort Study. PLoS Med, 2016. 13: e1002041. 
https://www.ncbi.nlm.nih.gov/pubmed/27327967

40.Kondo, A., et al. Neural tube defects: prevalence, etiology and prevention. Int J Urol, 2009. 16: 49. 
https://www.ncbi.nlm.nih.gov/pubmed/19120526

41.Sawin, K.J., et al. The National Spina Bifida Patient Registry: profile of a large cohort of participants from the first 10 clinics. J Pediatr, 2015. 166: 444. 
https://www.ncbi.nlm.nih.gov/pubmed/25444012

42.Wiener, J.S., et al. Bladder Management and Continence Outcomes in Adults with Spina Bifida: Results from the National Spina Bifida Patient Registry, 2009 to 2015. J Urol, 2018. 200: 187. 
https://www.ncbi.nlm.nih.gov/pubmed/29588216

43.Peyronnet, B., et al. Comparison of neurogenic lower urinary tract dysfunctions in open versus closed spinal dysraphism: A prospective cross-sectional study of 318 patients. Neurourol Urodyn, 2018. 37: 2818. 
https://www.ncbi.nlm.nih.gov/pubmed/30070396

44.Joussain, C., et al. Urological dysfunction in patients with hereditary spastic paraplegia. Neurourol Urodyn, 2019. 38: 1081. 
https://www.ncbi.nlm.nih.gov/pubmed/30848841

45.Bartolin, Z., et al. Relationship between clinical data and urodynamic findings in patients with lumbar intervertebral disk protrusion. Urol Res, 2002. 30: 219. 
https://www.ncbi.nlm.nih.gov/pubmed/12202938

46.Baker, M., et al. Urogenital symptoms in women with Tarlov cysts. J Obstet Gynaecol Res, 2018. 44: 1817. 
https://www.ncbi.nlm.nih.gov/pubmed/29974579

47.Hentzen, C., et al. Sacral Tarlov cysts: Neurophysiology abnormalities and correlation with pelvic sensory and visceral symptoms. Eur J Neurol, 2023. 30: 2838. 
https://www.ncbi.nlm.nih.gov/pubmed/37203934

48.Qadri, H.M., et al. Elsberg syndrome - A systematic review of existing scientific literature from 2000 - 2023. Pak J Med Sci, 2024. 40: S103. 
https://www.ncbi.nlm.nih.gov/pubmed/39703979

49.Lange, M.M., et al. Urinary and sexual dysfunction after rectal cancer treatment. Nat Rev Urol, 2011. 8: 51. 
https://www.ncbi.nlm.nih.gov/pubmed/21135876

50.Federation, I.D., IDF Diabetes Atlas, 6th edn. 2013, International Diabetes Federation: Brussels, Belgium. 
https://diabetesatlas.org/media/uploads/sites/3/2025/02/IDF-Atlas-6th-Edition-EN.pdf

51.Yuan, Z., et al. Diabetic cystopathy: A review. J Diabetes, 2015. 7: 442. 
https://www.ncbi.nlm.nih.gov/pubmed/25619174

52.Burns, R.T., et al. An analysis of urodynamic parameters in diabetic and nondiabetic women. Neurourol Urodyn, 2024. 43: 1600. 
https://www.ncbi.nlm.nih.gov/pubmed/38808694

53.Tateno, F., et al. Lower Urinary Tract Symptoms in Myasthenia Gravis. Case Rep Neurol, 2021. 13: 490. 
https://www.ncbi.nlm.nih.gov/pubmed/34413752

54.Pugliatti, M., et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol, 2006. 13: 700. 
https://www.ncbi.nlm.nih.gov/pubmed/16834700

55.de Seze, M., et al. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler, 2007. 13: 915. 
https://www.ncbi.nlm.nih.gov/pubmed/17881401

56.Sharifiaghdas, F., et al. Multiple sclerosis and lower urinary tract symptoms: A survey of prevalence, characteristic and urological evaluations. SAGE Open Med, 2023. 11: 20503121231178047. 
https://www.ncbi.nlm.nih.gov/pubmed/37384196

57.Giannopapas, V., et al. Interactions between fatigue and urinary quality of life in patients with Multiple Sclerosis. J Clin Neurosci, 2024. 120: 87. 
https://www.ncbi.nlm.nih.gov/pubmed/38237491

58.Jaekel, A.K., et al. The Impact of Urodynamic Findings on Fatigue and Depression in People with Multiple Sclerosis. Biomedicines, 2025. 13. 
https://www.ncbi.nlm.nih.gov/pubmed/40149578

59.Islamoska, S., et al. The impact of bladder problems on well-being in multiple sclerosis - A cross-sectional study. Mult Scler Relat Disord, 2024. 87: 105661. 
https://www.ncbi.nlm.nih.gov/pubmed/38728957

60.Al Dandan, H.B., et al. Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis. Int J MS Care, 2020. 22: 91. 
https://www.ncbi.nlm.nih.gov/pubmed/32410904

61.Gajewski, J.B., et al. An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD). Neurourol Urodyn, 2018. 37: 1152. 
https://www.ncbi.nlm.nih.gov/pubmed/29149505

62.Liao, L. A new comprehensive classification system for both lower and upper urinary tract dysfunction in patients with neurogenic bladder. Urol Int, 2015. 94: 244. 
https://www.ncbi.nlm.nih.gov/pubmed/25115367

63.Garcia Fadrique, G., et al. Urodynamic Differences between Complete and Incomplete Spinal Cord Injuries with Neurogenic Detrusor Overactivity. Urol Int, 2020. 104: 273. 
https://www.ncbi.nlm.nih.gov/pubmed/31461727

64.Ahlberg, J., et al. Neurological signs are common in patients with urodynamically verified “idiopathic” bladder overactivity. Neurourol Urodyn, 2002. 21: 65. 
https://www.ncbi.nlm.nih.gov/pubmed/11835426

65.Borau, A., et al. A systematic review of the diagnosis and treatment of patients with neurogenic hyperactivity of the detrusor muscle. Actas Urol Esp (Engl Ed), 2018. 42: 5. 
https://www.ncbi.nlm.nih.gov/pubmed/28413135

66.Musco, S., et al. Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: A systematic review. Neurourol Urodyn, 2018. 37: 1522. 
https://www.ncbi.nlm.nih.gov/pubmed/29392753

67.Farrelly, E., et al. The Stockholm Spinal Cord Uro Study: 3. Urodynamic characteristics in a regional prevalence group of persons with spinal cord injury and indications for improved follow-up. Scand J Urol, 2021. 55: 412. 
https://www.ncbi.nlm.nih.gov/pubmed/34279177

68.Mahajan, S.T., et al. The prevalence of urinary catheterization in women and men with multiple sclerosis. J Spinal Cord Med, 2013. 36: 632. 
https://www.ncbi.nlm.nih.gov/pubmed/24090205

69.Loftus, C.J., et al. Bladder management is the top health concern among adults with a spinal cord injury. Neurourol Urodyn, 2024. 43: 449. 
https://www.ncbi.nlm.nih.gov/pubmed/38116927

70.Bors, E., et al. History and physical examination in neurological urology. J Urol, 1960. 83: 759. 
https://www.ncbi.nlm.nih.gov/pubmed/13802958

71.Cameron, A.P., et al. The Severity of Bowel Dysfunction in Patients with Neurogenic Bladder. J Urol, 2015. 194: 1336. 
https://www.ncbi.nlm.nih.gov/pubmed/25956470

72.Vodusek, D.B. Lower urinary tract and sexual dysfunction in neurological patients. Eur Neurol, 2014. 72: 109. 
https://www.ncbi.nlm.nih.gov/pubmed/24993182

73.Linsenmeyer, T.A., et al. Accuracy of individuals with spinal cord injury at predicting urinary tract infections based on their symptoms. J Spinal Cord Med, 2003. 26: 352. 
https://www.ncbi.nlm.nih.gov/pubmed/14992336

74.Massa, L.M., et al. Validity, accuracy, and predictive value of urinary tract infection signs and symptoms in individuals with spinal cord injury on intermittent catheterization. J Spinal Cord Med, 2009. 32: 568. 
https://www.ncbi.nlm.nih.gov/pubmed/20025153

75.Haegel, A., et al. Bladder Diary Feasibility and Reliability in Neurogenic Lower Urinary Tract Dysfunction Patients. Neurourol Urodyn, 2025. 44: 1120. 
https://www.ncbi.nlm.nih.gov/pubmed/40296612

76.Konstantinidis, C., et al. Optimal bladder diary duration for patients with suprapontine neurogenic lower urinary tract dysfunction. Int Braz J Urol, 2016. 42: 766. 
https://www.ncbi.nlm.nih.gov/pubmed/27564288

77.Henze, T. Managing specific symptoms in people with multiple sclerosis. Int MS J, 2005. 12: 60. 
https://www.ncbi.nlm.nih.gov/pubmed/16417816

78.Myers, J.B., et al. Patient Reported Bladder Related Symptoms and Quality of Life after Spinal Cord Injury with Different Bladder Management Strategies. J Urol, 2019. 202: 574. 
https://www.ncbi.nlm.nih.gov/pubmed/30958741

79.Moghalu, O., et al. Psychosocial aspects of health-related quality of life and the association with patient-reported bladder symptoms and satisfaction after spinal cord injury. Spinal Cord, 2021. 59: 987. 
https://www.ncbi.nlm.nih.gov/pubmed/33495582

80.Khalaf, K.M., et al. The impact of lower urinary tract symptoms on health-related quality of life among patients with multiple sclerosis. Neurourol Urodyn, 2016. 35: 48. 
https://www.ncbi.nlm.nih.gov/pubmed/25327401

81.Szymanski, K.M., et al. All Incontinence is Not Created Equal: Impact of Urinary and Fecal Incontinence on Quality of Life in Adults with Spina Bifida. J Urol, 2017. 197: 885. 
https://www.ncbi.nlm.nih.gov/pubmed/28131501

82.Pannek, J., et al. Does optimizing bladder management equal optimizing quality of life? Correlation between health-related quality of life and urodynamic parameters in patients with spinal cord lesions. Urology, 2009. 74: 263. 
https://www.ncbi.nlm.nih.gov/pubmed/19428089

83.Bonniaud, V., et al. Qualiveen, a urinary-disorder specific instrument: 0.5 corresponds to the minimal important difference. J Clin Epidemiol, 2008. 61: 505. 
https://www.ncbi.nlm.nih.gov/pubmed/18394545

84.Bonniaud, V., et al. Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen. J Urol, 2008. 180: 2592. 
https://www.ncbi.nlm.nih.gov/pubmed/18950816

85.Best, K.L., et al. Identifying and classifying quality of life tools for neurogenic bladder function after spinal cord injury: A systematic review. J Spinal Cord Med, 2017. 40: 505. 
https://www.ncbi.nlm.nih.gov/pubmed/27734771

86.Welk, B., et al. The creation and validation of a short form of the Neurogenic Bladder Symptom Score. Neurourol Urodyn, 2020. 39: 1162. 
https://www.ncbi.nlm.nih.gov/pubmed/32196732

87.Pariser, J.J., et al. Reliability and Validity of the Neurogenic Bladder Symptom Score in Adults with Cerebral Palsy. Urology, 2019. 128: 107. 
https://www.ncbi.nlm.nih.gov/pubmed/30890419

88.Gulick, E.E. Bowel management related quality of life in people with multiple sclerosis: psychometric evaluation of the QoL-BM measure. Int J Nurs Stud, 2011. 48: 1066. 
https://www.ncbi.nlm.nih.gov/pubmed/21377677

89.Turmel, N., et al. Lower urinary tract symptoms treatment constraints assessment (LUTS-TCA): a new tool for a global evaluation of neurogenic bladder treatments. World J Urol, 2019. 37: 1917. 
https://www.ncbi.nlm.nih.gov/pubmed/30511213

90.Tractenberg, R.E., et al. Clinical Profiles and Symptom Burden Estimates to Support Decision-Making Using the Urinary Symptom Questionnaire for People with Neurogenic Bladder (USQNB) using Intermittent Catheters. PM R, 2021. 13: 229. 
https://www.ncbi.nlm.nih.gov/pubmed/32860333

91.Foley, F.W., et al. The Multiple Sclerosis Intimacy and Sexuality Questionnaire -- re-validation and development of a 15-item version with a large US sample. Mult Scler, 2013. 19: 1197. 
https://www.ncbi.nlm.nih.gov/pubmed/23369892

92.Sanders, A.S., et al. The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 (MSISQ-19). Sexuality and Disability, 2000. 18: 3. 
https://doi.org/10.1023/A:1005421627154

93.t Hoen, L.A., et al. A Quality Assessment of Patient-Reported Outcome Measures for Sexual Function in Neurologic Patients Using the Consensus-based Standards for the Selection of Health Measurement Instruments Checklist: A Systematic Review. Eur Urol Focus, 2017. 3: 444. 
https://www.ncbi.nlm.nih.gov/pubmed/28753768

94.Tsang, B., et al. A systematic review and comparison of questionnaires in the management of spinal cord injury, multiple sclerosis and the neurogenic bladder. Neurourol Urodyn, 2016. 35: 354. 
https://www.ncbi.nlm.nih.gov/pubmed/25620137

95.Schurch, B., et al. Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence. Arch Phys Med Rehabil, 2007. 88: 646. 
https://www.ncbi.nlm.nih.gov/pubmed/17466735

96.Patel, D.P., et al. Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature. Neurourol Urodyn, 2016. 35: 8. 
https://www.ncbi.nlm.nih.gov/pubmed/25327455

97.Hollingworth, W., et al. Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes. Qual Life Res, 2010. 19: 323. 
https://www.ncbi.nlm.nih.gov/pubmed/20094804

98.Cella, D.F., et al. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology, 1996. 47: 129. 
https://www.ncbi.nlm.nih.gov/pubmed/8710066

99.Wesson, J.M., et al. The functional index for living with multiple sclerosis: development and validation of a new quality of life questionnaire. Mult Scler, 2009. 15: 1239. 
https://www.ncbi.nlm.nih.gov/pubmed/19737850

100.Gold, S.M., et al. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult Scler, 2001. 7: 119. 
https://www.ncbi.nlm.nih.gov/pubmed/11424632

101.Goodin, D.S. A questionnaire to assess neurological impairment in multiple sclerosis. Mult Scler, 1998. 4: 444. 
https://www.ncbi.nlm.nih.gov/pubmed/9839306

102.Marrie, R.A., et al. Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Mult Scler, 2003. 9: 621. 
https://www.ncbi.nlm.nih.gov/pubmed/14664477

103.Vickrey, B.G., et al. A health-related quality of life measure for multiple sclerosis. Qual Life Res, 1995. 4: 187. 
https://www.ncbi.nlm.nih.gov/pubmed/7613530

104.Honan, C.A., et al. The multiple sclerosis work difficulties questionnaire (MSWDQ): development of a shortened scale. Disabil Rehabil, 2014. 36: 635. 
https://www.ncbi.nlm.nih.gov/pubmed/23786346

105.Welk, B., et al. A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction. Neurourol Urodyn, 2018. 37: 2810. 
https://www.ncbi.nlm.nih.gov/pubmed/30168626

106.Bonniaud, V., et al. Measuring quality of life in multiple sclerosis patients with urinary disorders using the Qualiveen questionnaire. Arch Phys Med Rehabil, 2004. 85: 1317. 
https://www.ncbi.nlm.nih.gov/pubmed/15295759

107.Franceschini, M., et al. Follow-up in persons with traumatic spinal cord injury: questionnaire reliability. Eura Medicophys, 2006. 42: 211. 
https://www.ncbi.nlm.nih.gov/pubmed/17039217

108.Noreau, L., et al. Development and assessment of a community follow-up questionnaire for the Rick Hansen spinal cord injury registry. Arch Phys Med Rehabil, 2013. 94: 1753. 
https://www.ncbi.nlm.nih.gov/pubmed/23529142

109.Husmann, D.A. Mortality following augmentation cystoplasty: A transitional urologist’s viewpoint. J Pediatr Urol, 2017. 13: 358. 
https://www.ncbi.nlm.nih.gov/pubmed/28645552

110.Yang, C.C., et al. Bladder management in women with neurologic disabilities. Phys Med Rehabil Clin N Am, 2001. 12: 91. 
https://www.ncbi.nlm.nih.gov/pubmed/11853041

111.Podnar, S., et al. Protocol for clinical neurophysiologic examination of the pelvic floor. Neurourol Urodyn, 2001. 20: 669. 
https://www.ncbi.nlm.nih.gov/pubmed/11746548

112.Harrison, S., et al. Urinary incontinence in neurological disease: assessment and management. NICE Clinical Guideline 2012. [CG148]. 
https://www.nice.org.uk/guidance/cg148

113.Krassioukov, A., et al. International standards to document remaining autonomic function after spinal cord injury. J Spinal Cord Med, 2012. 35: 201. 
https://www.ncbi.nlm.nih.gov/pubmed/22925746

114.Walter, M., et al. Prediction of autonomic dysreflexia during urodynamics: a prospective cohort study. BMC Med, 2018. 16: 53. 
https://www.ncbi.nlm.nih.gov/pubmed/29650001

115.Liu, N., et al. Autonomic dysreflexia severity during urodynamics and cystoscopy in individuals with spinal cord injury. Spinal Cord, 2013. 51: 863. 
https://www.ncbi.nlm.nih.gov/pubmed/24060768

116.Palanjian, R., et al. Impact of Bladder Management Strategies on Autonomic Dysreflexia Severity in People With Spinal Cord Injuries. Neurourol Urodyn, 2025. 44: 754. 
https://www.ncbi.nlm.nih.gov/pubmed/39912231

117.Labat, J.J., et al. Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourol Urodyn, 2008. 27: 306. 
https://www.ncbi.nlm.nih.gov/pubmed/17828787

118.Brown, D., Atlas of regional anesthesia. 3rd. ed. 2006, Philadelphia

119.Standring, S., Gray’s anatomy, . 40th ed. 2008.

120.Bellucci, C.H., et al. Neurogenic lower urinary tract dysfunction--do we need same session repeat urodynamic investigations? J Urol, 2012. 187: 1318. 
https://www.ncbi.nlm.nih.gov/pubmed/22341264

121.Walter, M., et al. Autonomic dysreflexia and repeatability of cardiovascular changes during same session repeat urodynamic investigation in women with spinal cord injury. World J Urol, 2016. 34: 391. 
https://www.ncbi.nlm.nih.gov/pubmed/26055644

122.Gammie, A., et al. International Continence Society guidelines on urodynamic equipment performance. Neurourol Urodyn, 2014. 33: 370. 
https://www.ncbi.nlm.nih.gov/pubmed/24390971

123.Anderson, C.E., et al. Temporal development of unfavourable urodynamic parameters during the first year after spinal cord injury. BJU Int, 2023. 131: 503. 
https://www.ncbi.nlm.nih.gov/pubmed/36221991

124.Vasudeva, P., et al. Urodynamic assessment of detrusor function in the very acute phase of traumatic spinal cord injury: A prospective cohort study. Indian J Urol, 2024. 40: 31. 
https://www.ncbi.nlm.nih.gov/pubmed/38314069

125.Kozomara, M., et al. Neurogenic Lower Urinary Tract Dysfunction in the First Year After Spinal Cord Injury: A Descriptive Study of Urodynamic Findings. J Urol, 2023. 209: 225. 
https://www.ncbi.nlm.nih.gov/pubmed/36263681

126.McGuire, E.J., et al. Leak-point pressures. Urol Clin North Am, 1996. 23: 253. 
https://www.ncbi.nlm.nih.gov/pubmed/8659025

127.Ozkan, B., et al. Which factors predict upper urinary tract deterioration in overactive neurogenic bladder dysfunction? Urology, 2005. 66: 99. 
https://www.ncbi.nlm.nih.gov/pubmed/15992868

128.Wang, Q.W., et al. Is it possible to use urodynamic variables to predict upper urinary tract dilatation in children with neurogenic bladder-sphincter dysfunction? BJU Int, 2006. 98: 1295. 
https://www.ncbi.nlm.nih.gov/pubmed/17034510

129.Linsenmeyer, T.A., et al. The impact of urodynamic parameters on the upper tracts of spinal cord injured men who void reflexly. J Spinal Cord Med, 1998. 21: 15. 
https://www.ncbi.nlm.nih.gov/pubmed/9541882

130.McGuire, E.J., et al. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol, 1981. 126: 205. 
https://www.ncbi.nlm.nih.gov/pubmed/7196460

131.Krongrad, A., et al. Bladder neck dysynergia in spinal cord injury. Am J Phys Med Rehabil, 1996. 75: 204. 
https://www.ncbi.nlm.nih.gov/pubmed/8663928

132.Weld, K.J., et al. Clinical significance of detrusor sphincter dyssynergia type in patients with post-traumatic spinal cord injury. Urology, 2000. 56: 565. 
https://www.ncbi.nlm.nih.gov/pubmed/11018603

133.Rossier, A.B., et al. 5-microtransducer catheter in evaluation of neurogenic bladder function. Urology, 1986. 27: 371. 
https://www.ncbi.nlm.nih.gov/pubmed/3962062

134.Al-Ali, M., et al. A 10 year review of the endoscopic treatment of 125 spinal cord injured patients with vesical outlet obstruction: does bladder neck dyssynergia exist? Paraplegia, 1996. 34: 34. 
https://www.ncbi.nlm.nih.gov/pubmed/8848321

135.Bacsu, C.D., et al. Diagnosing detrusor sphincter dyssynergia in the neurological patient. BJU Int, 2012. 109 Suppl 3: 31. 
https://www.ncbi.nlm.nih.gov/pubmed/22458490

136.Lose, G., et al. Standardisation of urethral pressure measurement: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn, 2002. 21: 258. 
https://www.ncbi.nlm.nih.gov/pubmed/11948719

137.Marks, B.K., et al. Videourodynamics: indications and technique. Urol Clin North Am, 2014. 41: 383. 
https://www.ncbi.nlm.nih.gov/pubmed/25063594

138.Francot, M., et al. Indications and added value of videourodynamics in men with spinal cord injury. BJUI Compass, 2024. 5: 761. 
https://www.ncbi.nlm.nih.gov/pubmed/39157163

139.Virseda, M., et al. Reliability of ambulatory urodynamics in patients with spinal cord injuries. Neurourol Urodyn, 2013. 32: 387. 
https://www.ncbi.nlm.nih.gov/pubmed/23002043

140.Virseda-Chamorro, M., et al. Comparison of ambulatory versus video urodynamics in patients with spinal cord injury. Spinal Cord, 2014. 52: 551. 
https://www.ncbi.nlm.nih.gov/pubmed/24663000

141.Geirsson, G., et al. The ice-water test--a simple and valuable supplement to routine cystometry. Br J Urol, 1993. 71: 681. 
https://www.ncbi.nlm.nih.gov/pubmed/8343894

142.Geirsson, G., et al. Pressure, volume and infusion speed criteria for the ice-water test. Br J Urol, 1994. 73: 498. 
https://www.ncbi.nlm.nih.gov/pubmed/8012770

143.Kozomara, M., et al. Is Detrusor Contraction during Rapid Bladder Filling Caused by Cold or Warm Water? A Randomized, Controlled, Double-Blind Trial. J Urol, 2018. 199: 223. 
https://www.ncbi.nlm.nih.gov/pubmed/28751267

144.Al-Hayek, S., et al. The 50-year history of the ice water test in urology. J Urol, 2010. 183: 1686. 
https://www.ncbi.nlm.nih.gov/pubmed/20299050

145.Lapides, J. Neurogenic bladder. Principles of treatment. Urol Clin North Am, 1974. 1: 81. 
https://www.ncbi.nlm.nih.gov/pubmed/4428540

146.Riedl, C.R., et al. Electromotive administration of intravesical bethanechol and the clinical impact on acontractile detrusor management: introduction of a new test. J Urol, 2000. 164: 2108. 
https://www.ncbi.nlm.nih.gov/pubmed/11061937

147.Podnar, S., et al. Lower urinary tract dysfunction in patients with peripheral nervous system lesions. Handb Clin Neurol, 2015. 130: 203. 
https://www.ncbi.nlm.nih.gov/pubmed/26003246

148.Ouyang, L., et al. Characteristics and survival of patients with end stage renal disease and spina bifida in the United States renal data system. J Urol, 2015. 193: 558. 
https://www.ncbi.nlm.nih.gov/pubmed/25167993

149.Lane, G.I., et al. Clinical outcomes of non-surgical management of detrusor leak point pressures above 40 cm water in adults with congenital neurogenic bladder. Neurourol Urodyn, 2018. 37: 1943. 
https://www.ncbi.nlm.nih.gov/pubmed/29488655

150.Lawrenson, R., et al. Renal failure in patients with neurogenic lower urinary tract dysfunction. Neuroepidemiology, 2001. 20: 138. 
https://www.ncbi.nlm.nih.gov/pubmed/11359083

151.Mingat, N., et al. Prospective study of methods of renal function evaluation in patients with neurogenic bladder dysfunction. Urology, 2013. 82: 1032. 
https://www.ncbi.nlm.nih.gov/pubmed/24001705

152.Averbeck, M.A., et al. Follow-up of the neuro-urological patient: a systematic review. BJU Int, 2015. 115 Suppl 6: 39. 
https://www.ncbi.nlm.nih.gov/pubmed/25891319

153.Stöhrer, M., et al. Diagnosis and treatment of bladder dysfunction in spinal cord injury patients. Eur Urol Update Series 1994. 3: 170.

154.Apostolidis, A., et al., Neurologic Urinary and Faecal Incontinence, in Incontinence 6th Edition, P. Abrams, L. Cardozo, S. Khoury & A. Wein, Editors. 2017. 
http://www.icud.info/incontinence.html

155.Chamberlain, J.D., et al. Mortality and longevity after a spinal cord injury: systematic review and meta-analysis. Neuroepidemiology, 2015. 44: 182. 
https://www.ncbi.nlm.nih.gov/pubmed/25997873

156.Game, X., et al. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol, 2008. 53: 613. 
https://www.ncbi.nlm.nih.gov/pubmed/17804150

157.Frankel, H.L., et al. Long-term survival in spinal cord injury: a fifty year investigation. Spinal Cord, 1998. 36: 266. 
https://www.ncbi.nlm.nih.gov/pubmed/9589527

158.Jamil, F. Towards a catheter free status in neurogenic bladder dysfunction: a review of bladder management options in spinal cord injury (SCI). Spinal Cord, 2001. 39: 355. 
https://www.ncbi.nlm.nih.gov/pubmed/11464308

159.Thietje, R., et al. Mortality in patients with traumatic spinal cord injury: descriptive analysis of 62 deceased subjects. J Spinal Cord Med, 2011. 34: 482. 
https://www.ncbi.nlm.nih.gov/pubmed/22118255

160.Hackler, R.H. A 25-year prospective mortality study in the spinal cord injured patient: comparison with the long-term living paraplegic. J Urol, 1977. 117: 486. 
https://www.ncbi.nlm.nih.gov/pubmed/850323

161.Rodrigues, P., et al. Involuntary detrusor contraction is a frequent finding in patients with recurrent urinary tract infections. Urol Int, 2014. 93: 67. 
https://www.ncbi.nlm.nih.gov/pubmed/25011551

162.Bauer, S.B. Neurogenic bladder: etiology and assessment. Pediatr Nephrol, 2008. 23: 541. 
https://www.ncbi.nlm.nih.gov/pubmed/18270749

163.Barbalias, G.A., et al. Critical evaluation of the Crede maneuver: a urodynamic study of 207 patients. J Urol, 1983. 130: 720. 
https://www.ncbi.nlm.nih.gov/pubmed/6887405

164.Reinberg, Y., et al. Renal rupture after the Crede maneuver. J Pediatr, 1994. 124: 279. 
https://www.ncbi.nlm.nih.gov/pubmed/8301439

165.Wyndaele, J.J., et al. Neurologic urinary incontinence. Neurourol Urodyn, 2010. 29: 159. 
https://www.ncbi.nlm.nih.gov/pubmed/20025021

166.Menon, E.B., et al. Bladder training in patients with spinal cord injury. Urology, 1992. 40: 425. 
https://www.ncbi.nlm.nih.gov/pubmed/1441039

167.Furusawa, K., et al. Incidence of symptomatic autonomic dysreflexia varies according to the bowel and bladder management techniques in patients with spinal cord injury. Spinal Cord, 2011. 49: 49. 
https://www.ncbi.nlm.nih.gov/pubmed/20697419

168.Consortium for Spinal Cord, M. Outcomes following traumatic spinal cord injury: clinical practice guidelines for health-care professionals. J Spinal Cord Med, 2000. 23: 289. 
https://www.ncbi.nlm.nih.gov/pubmed/17536300

169.El-Masri, W.S., et al. Long-term follow-up study of outcomes of bladder management in spinal cord injury patients under the care of the Midlands Centre for Spinal Injuries in Oswestry. Spinal Cord, 2012. 50: 14. 
https://www.ncbi.nlm.nih.gov/pubmed/21808256

170.Fall, M., et al. Electrical stimulation. A physiologic approach to the treatment of urinary incontinence. Urol Clin North Am, 1991. 18: 393. 
https://www.ncbi.nlm.nih.gov/pubmed/2017820

171.Sundin, T., et al. Detrusor inhibition induced from mechanical stimulation of the anal region and from electrical stimulation of pudendal nerve afferents. An experimental study in cats. Invest Urol, 1974. 11: 374. 
https://www.ncbi.nlm.nih.gov/pubmed/4815623

172.Gross, T., et al. Transcutaneous Electrical Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review. Eur Urol, 2016. 69: 1102. 
https://www.ncbi.nlm.nih.gov/pubmed/26831506

173.Vaughan, C.P., et al. Behavioral therapy for urinary symptoms in Parkinson’s disease: A randomized clinical trial. Neurourol Urodyn, 2019. 38: 1737. 
https://www.ncbi.nlm.nih.gov/pubmed/31187552

174.McDonald, C., et al. Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial. Neurology, 2020. 94: e1427. 
https://www.ncbi.nlm.nih.gov/pubmed/32054791

175.Wang, F., et al. Exploring the Effect of Bladder Functional Training Combined with Repetitive Sacral Root Magnetic Stimulation in the Treatment of Neurogenic Bladder. World Neurosurg, 2023. 177: e440. 
https://www.ncbi.nlm.nih.gov/pubmed/37356478

176.Ozden, F., et al. The effect of pelvic floor muscle training on urinary incontinence in patients with stroke: a systematic review and meta-analysis. Ir J Med Sci, 2023. 192: 1481. 
https://www.ncbi.nlm.nih.gov/pubmed/35776264

177.Kajbafvala, M., et al. Pelvic floor muscle training in multiple sclerosis patients with lower urinary tract dysfunction: A systematic review and meta-analysis. Mult Scler Relat Disord, 2022. 59: 103559. 
https://www.ncbi.nlm.nih.gov/pubmed/35144089

178.Zhang, X., et al. Effect of pelvic floor muscle training on pelvic floor muscle function and lower urinary tract symptoms in stroke patients: a systematic review. Physiother Theory Pract, 2023. 39: 1342. 
https://www.ncbi.nlm.nih.gov/pubmed/35230216

179.Gu, J., et al. Clinical efficacy of bladder function training combined with pelvic floor biofeedback electrical stimulation on neurogenic bladder and its impact on urodynamics. Pak J Med Sci, 2025. 41: 251. 
https://www.ncbi.nlm.nih.gov/pubmed/39867774

180.Bulbul, S.B., et al. Effects of pelvic floor muscle training applied with telerehabilitation in patients with multiple sclerosis having lower urinary track symptoms: A randomized controlled trial. Health Care Women Int, 2024. 45: 731. 
https://www.ncbi.nlm.nih.gov/pubmed/37010419

181.Deodato, M., et al. Comparison of different telerehabilitation protocols for urogenital symptoms in females with multiple sclerosis: a randomized controlled trial. Neurol Sci, 2024. 45: 5501. 
https://www.ncbi.nlm.nih.gov/pubmed/39223424

182.Yavas, I., et al. Feasibility of Telerehabilitation-Based Pelvic Floor Muscle Training for Urinary Incontinence in People With Multiple Sclerosis: A Randomized, Controlled, Assessor-Blinded Study. J Neurol Phys Ther, 2023. 47: 217. 
https://www.ncbi.nlm.nih.gov/pubmed/37306430

183.Ramezani, M., et al. Concurrent multi-session anodal trans-cranial direct current stimulation enhances pelvic floor muscle training effectiveness for female patients with multiple sclerosis suffering from urinary incontinence and pelvic floor dysfunction: a randomized clinical trial study. Int Urogynecol J, 2023. 34: 1771. 
https://www.ncbi.nlm.nih.gov/pubmed/36719448

184.Bapir, R., et al. Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials. Arch Ital Urol Androl, 2022. 94: 492. 
https://www.ncbi.nlm.nih.gov/pubmed/36576454

185.Ali, M.U., et al. Effects of nonsurgical, minimally or noninvasive therapies for urinary incontinence due to neurogenic bladder: a systematic review and meta-analysis. Ther Adv Chronic Dis, 2022. 13: 20406223211063059. 
https://www.ncbi.nlm.nih.gov/pubmed/35321402

186.Castel-Lacanal, E., et al. Evaluation of transcutaneous electrical tibial nerve stimulation in lower urinary tract dysfunction secondary to a parkinsonian syndrome: Uroparktens-a multicenter randomized placebo-controlled study. World J Urol, 2025. 43: 214. 
https://www.ncbi.nlm.nih.gov/pubmed/40192925

187.Chen, Y., et al. The effectiveness and safety of oral medications, onabotulinumtoxinA (three doses) and transcutaneous tibial nerve stimulation as non or minimally invasive treatment for the management of neurogenic detrusor overactivity in adults: a systematic review and network meta-analysis. Int J Surg, 2023. 109: 1430. 
https://www.ncbi.nlm.nih.gov/pubmed/36974676

188.Ge, Q., et al. Efficacy of peripheral electrical nerve stimulation on improvements of urodynamics and voiding diary in patients with neurogenic lower urinary tract dysfunction: a systematic review and meta-analysis. Int J Surg, 2023. 109: 1342. 
https://www.ncbi.nlm.nih.gov/pubmed/37026834

189.Jiang, Y., et al. Transcutaneous Electrical Stimulation for Neurogenic Bladder After Spinal Cord Injury: A Systematic Review and Meta-Analysis. Neuromodulation, 2024. 27: 604. 
https://www.ncbi.nlm.nih.gov/pubmed/37642626

190.Ojha, R., et al. Neuromodulation of spinal reflex pathway for the treatment of detrusor overactivity by medial plantar nerve stimulation at surface of sole of foot in patients with spinal cord injury. J Neurosci Rural Pract, 2023. 14: 495. 
https://www.ncbi.nlm.nih.gov/pubmed/37692814

191.Liu, Y., et al. Effects of Transcutaneous Electrical Nerve Stimulation at Two Frequencies on Urinary Incontinence in Poststroke Patients: A Randomized Controlled Trial. Am J Phys Med Rehabil, 2016. 95: 183. 
https://www.ncbi.nlm.nih.gov/pubmed/26259053

192.Guo, G.Y., et al. Effectiveness of neuromuscular electrical stimulation therapy in patients with urinary incontinence after stroke: A randomized sham controlled trial. Medicine (Baltimore), 2018. 97: e13702. 
https://www.ncbi.nlm.nih.gov/pubmed/30593142

193.Shen, S.X., et al. A retrospective study of neuromuscular electrical stimulation for treating women with post-stroke incontinence. Medicine (Baltimore), 2018. 97: e11264. 
https://www.ncbi.nlm.nih.gov/pubmed/29952999

194.Smith, M.D., et al. Neuromodulation for Storage Lower Urinary Tract Symptoms in Parkinson Disease: A Systematic Review. Neuromodulation, 2022. 25: 1076. 
https://www.ncbi.nlm.nih.gov/pubmed/35300922

195.Smith, M.D., et al. Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Symptoms in Parkinson’s Disease: Results from a Phase II Randomized Control Trial (STRIPE). Mov Disord, 2025. 40: 1291. 
https://www.ncbi.nlm.nih.gov/pubmed/40243214

196.Marzouk, M.H., et al. Posterior tibial nerve stimulation as a neuromodulation therapy in treatment of neurogenic overactive bladder in multiple sclerosis: A prospective randomized controlled study. Mult Scler Relat Disord, 2022. 68: 104252. 
https://www.ncbi.nlm.nih.gov/pubmed/36274285

197.Stampas, A., et al. Bladder Neuromodulation in Acute Spinal Cord Injury via Transcutaneous Tibial Nerve Stimulation: Cystometrogram and Autonomic Nervous System Evidence From a Randomized Control Pilot Trial. Front Neurosci, 2019. 13: 119. 
https://www.ncbi.nlm.nih.gov/pubmed/30837835

198.Stampas, A., et al. Safety, Feasibility, and Efficacy of Transcutaneous Tibial Nerve Stimulation in Acute Spinal Cord Injury Neurogenic Bladder: A Randomized Control Pilot Trial. Neuromodulation, 2019. 22: 716. 
https://www.ncbi.nlm.nih.gov/pubmed/30284350

199.Sahu, S., et al. Transcutaneous neuromodulation versus oxybutynin for neurogenic detrusor overactivity in persons with spinal cord injury: A randomized, investigator blinded, parallel group, non-inferiority controlled trial. J Spinal Cord Med, 2025. 48: 621. 
https://www.ncbi.nlm.nih.gov/pubmed/38958641

200.Stampas, A., et al. Reduction of Overactive Bladder Medications in Spinal Cord Injury With Self-Administered Neuromodulation: A Randomized Trial. J Urol, 2024. 212: 800. 
https://www.ncbi.nlm.nih.gov/pubmed/39093916

201.Parittotokkaporn, S., et al. Non-invasive neuromodulation for bowel, bladder and sexual restoration following spinal cord injury: A systematic review. Clin Neurol Neurosurg, 2020. 194: 105822. 
https://www.ncbi.nlm.nih.gov/pubmed/32334284

202.Daia, C., et al. Interferential electrical stimulation for improved bladder management following spinal cord injury. Biomed Rep, 2019. 11: 115. 
https://www.ncbi.nlm.nih.gov/pubmed/31423306

203.McClurg, D., et al. Neuromuscular electrical stimulation and the treatment of lower urinary tract dysfunction in multiple sclerosis--a double blind, placebo controlled, randomised clinical trial. Neurourol Urodyn, 2008. 27: 231. 
https://www.ncbi.nlm.nih.gov/pubmed/17705160

204.Silva Ferreira, A.P., et al. A Controlled Clinical Trial on the Effects of Exercise on Lower Urinary Tract Symptoms in Women With Multiple Sclerosis. Am J Phys Med Rehabil, 2019. 98: 777. 
https://www.ncbi.nlm.nih.gov/pubmed/30932917

205.McClurg, D., et al. Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study. Neurourol Urodyn, 2006. 25: 337. 
https://www.ncbi.nlm.nih.gov/pubmed/16637070

206.Ferreira, A.P., et al. Impact of a Pelvic Floor Training Program Among Women with Multiple Sclerosis: A Controlled Clinical Trial. Am J Phys Med Rehabil, 2016. 95: 1. 
https://www.ncbi.nlm.nih.gov/pubmed/25888662

207.Elmelund, M., et al. The effect of pelvic floor muscle training and intravaginal electrical stimulation on urinary incontinence in women with incomplete spinal cord injury: an investigator-blinded parallel randomized clinical trial. Int Urogynecol J, 2018. 29: 1597. 
https://www.ncbi.nlm.nih.gov/pubmed/29574482

208.Hagerty, J.A., et al. Intravesical electrotherapy for neurogenic bladder dysfunction: a 22-year experience. J Urol, 2007. 178: 1680. 
https://www.ncbi.nlm.nih.gov/pubmed/17707024

209.Primus, G., et al. Restoration of micturition in patients with acontractile and hypocontractile detrusor by transurethral electrical bladder stimulation. Neurourol Urodyn, 1996. 15: 489. 
https://www.ncbi.nlm.nih.gov/pubmed/8857617

210.Lombardi, G., et al. Clinical efficacy of intravesical electrostimulation on incomplete spinal cord patients suffering from chronic neurogenic non-obstructive retention: a 15-year single centre retrospective study. Spinal Cord, 2013. 51: 232. 
https://www.ncbi.nlm.nih.gov/pubmed/23147136

211.Siregar, R.A.F., et al. Efficacy in Using Urodynamic Parameters of Intravesical Electrical Stimulation for Detrusor Underactivity. Urol Res Pract, 2024. 50: 121. 
https://www.ncbi.nlm.nih.gov/pubmed/38797996

212.Nardone, R., et al. Transcranial magnetic stimulation and bladder function: A systematic review. Clin Neurophysiol, 2019. 130: 2032. 
https://www.ncbi.nlm.nih.gov/pubmed/31541980

213.El-Habashy, H., et al. The effect of cortical versus sacral repetitive magnetic stimulation on lower urinary tract dysfunction in patients with multiple sclerosis. Acta Neurol Belg, 2020. 120: 141. 
https://www.ncbi.nlm.nih.gov/pubmed/31828602

214.Chen, J., et al. A randomized controlled trial of low-frequency repeated transcranial magnetic stimulation in patients with poststroke neurogenic bladder. Sci Rep, 2024. 14: 18404. 
https://www.ncbi.nlm.nih.gov/pubmed/39117697

215.Raheem, O.M.A., et al. Comparative study on the Impact of Transcranial Magnetic stimulation and Bio-feedback on overactive bladder in multiple sclerosis patients: a Randomized Clinical Trial. Neurol Sci, 2025. 46: 1291. 
https://www.ncbi.nlm.nih.gov/pubmed/39433600

216.Atak Cakir, P., et al. Effect of neuromodulation on neurogenic bladder in women with multiple sclerosis: a pilot randomized controlled trial. Neurodegener Dis Manag, 2025. 15: 57. 
https://www.ncbi.nlm.nih.gov/pubmed/40211880

217.Yu, X., et al. Meta-analysis of the curative effect of sacral nerve magnetic stimulation on neurogenic bladder after spinal cord injury. Medicine (Baltimore), 2024. 103: e40150. 
https://www.ncbi.nlm.nih.gov/pubmed/39432614

218.Yi, M., et al. Clinical Efficacy of Electroacupuncture at Sacral Four Points Combined with Moxibustion at Abdominal Three Points for Treating Post-Stroke Urinary Incontinence: Observations on Urodynamics, Quality of Life, and Safety. Arch Esp Urol, 2024. 77: 732. 
https://www.ncbi.nlm.nih.gov/pubmed/39238296

219.Lu, J., et al. Urodynamic analysis of the effect of electroacupuncture at different acupoints on the bladder after spinal cord injury. Neurourol Urodyn, 2024. 43: 2065. 
https://www.ncbi.nlm.nih.gov/pubmed/38953180

220.Zhang, W., et al. Electroacupuncture for urinary retention after stroke: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Clin Pract, 2024. 57: 101877. 
https://www.ncbi.nlm.nih.gov/pubmed/38996656

221.Thomas, L.H., et al. Treatment of urinary incontinence after stroke in adults. Cochrane Database Syst Rev, 2008. 2008: CD004462. 
https://www.ncbi.nlm.nih.gov/pubmed/18254050

222.Yeo, L., et al. Urinary tract dysfunction in Parkinson’s disease: a review. Int Urol Nephrol, 2012. 44: 415. 
https://www.ncbi.nlm.nih.gov/pubmed/21553114

223.Phe, V., et al. Management of neurogenic bladder in patients with multiple sclerosis. Nat Rev Urol, 2016. 13: 275. 
https://www.ncbi.nlm.nih.gov/pubmed/27030526

224.Andersson, K.E. Antimuscarinic mechanisms and the overactive detrusor: an update. Eur Urol, 2011. 59: 377. 
https://www.ncbi.nlm.nih.gov/pubmed/21168951

225.Bennett, N., et al. Can higher doses of oxybutynin improve efficacy in neurogenic bladder? J Urol, 2004. 171: 749. 
https://www.ncbi.nlm.nih.gov/pubmed/14713802

226.Horstmann, M., et al. Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage. Neurourol Urodyn, 2006. 25: 441. 
https://www.ncbi.nlm.nih.gov/pubmed/16847942

227.Kennelly, M.J., et al. Overactive bladder: pharmacologic treatments in the neurogenic population. Rev Urol, 2008. 10: 182. 
https://www.ncbi.nlm.nih.gov/pubmed/18836537

228.Madersbacher, H., et al. Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics. Spinal Cord, 2013. 51: 432. 
https://www.ncbi.nlm.nih.gov/pubmed/23743498

229.Madhuvrata, P., et al. Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis. Eur Urol, 2012. 62: 816. 
https://www.ncbi.nlm.nih.gov/pubmed/22397851

230.Stohrer, M., et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol, 2009. 56: 81. 
https://www.ncbi.nlm.nih.gov/pubmed/19403235

231.Mehnert, U., et al. The management of urinary incontinence in the male neurological patient. Curr Opin Urol, 2014. 24: 586. 
https://www.ncbi.nlm.nih.gov/pubmed/25389549

232.Stothers, L., et al. An integrative review of standardized clinical evaluation tool utilization in anticholinergic drug trials for neurogenic lower urinary tract dysfunction. Spinal Cord, 2016. 54: 1114. 
https://www.ncbi.nlm.nih.gov/pubmed/27241452

233.Amend, B., et al. Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects. Eur Urol, 2008. 53: 1021. 
https://www.ncbi.nlm.nih.gov/pubmed/18243516

234.Boonjaraspinyo, S., et al. The Long-Term, Real-World Effects of Oxybutynin on Pressure Reservoir Function in the Neurogenic Bladder after Spinal Cord Injury: A Retrospective Cohort Study. J Clin Med, 2024. 13: 4514. 
https://www.ncbi.nlm.nih.gov/pubmed/39124780

235.Chanchlani, R., et al. Role of gabapentin in the management of neurogenic overactive bladders: A systematic review. Cent European J Urol, 2025. 78: 61. 
https://www.ncbi.nlm.nih.gov/pubmed/40371430

236.Tijnagel, M.J., et al. Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin. BMC Urol, 2017. 17: 30. 
https://www.ncbi.nlm.nih.gov/pubmed/28403849

237.Cameron, A.P., et al. Combination drug therapy improves compliance of the neurogenic bladder. J Urol, 2009. 182: 1062. 
https://www.ncbi.nlm.nih.gov/pubmed/19616807

238.Isik, A.T., et al. Trospium and cognition in patients with late onset Alzheimer disease. J Nutr Health Aging, 2009. 13: 672. 
https://www.ncbi.nlm.nih.gov/pubmed/19657549

239.Menarini, M., et al. Trospium chloride in patients with neurogenic detrusor overactivity: is dose titration of benefit to the patients? Int J Clin Pharmacol Ther, 2006. 44: 623. 
https://www.ncbi.nlm.nih.gov/pubmed/17190372

240.Ethans, K.D., et al. Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity. J Spinal Cord Med, 2004. 27: 214. 
https://www.ncbi.nlm.nih.gov/pubmed/15478523

241.McKeage, K. Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms. Clin Drug Investig, 2013. 33: 71. 
https://www.ncbi.nlm.nih.gov/pubmed/23288694

242.Nicholas, R.S., et al. Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database Syst Rev, 2009: CD004193. 
https://www.ncbi.nlm.nih.gov/pubmed/19160231

243.van Rey, F., et al. Solifenacin in multiple sclerosis patients with overactive bladder: a prospective study. Adv Urol, 2011. 2011: 834753. 
https://www.ncbi.nlm.nih.gov/pubmed/21687581

244.Bycroft, J., et al. The effect of darifenacin on neurogenic detrusor overactivity in patients with spinal cord injury. Neurourol Urodyn 2003. 22: A190. 
http://www.ics.org/Abstracts/Publish/41/000190.pdf

245.Amarenco, G., et al. Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study. Neurourol Urodyn, 2017. 36: 414. 
https://www.ncbi.nlm.nih.gov/pubmed/26714009

246.Carl, S., et al. Up-01.88. Urology, 2006. 68: 250. 
https://www.goldjournal.net/article/S0090-4295(06)01724-9/fulltext

247.Zesiewicz, T.A., et al. Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson’s disease. Parkinsonism Relat Disord, 2015. 21: 514. 
https://www.ncbi.nlm.nih.gov/pubmed/25814050

248.Hajebrahimi, S., et al. Safety and Efficacy of Trospium Chloride and Solifenacin in Stroke-Induced Neurogenic Lower Urinary Tract Dysfunction: A Randomized Controlled Trial. Neurourol Urodyn, 2025. 44: 85. 
https://www.ncbi.nlm.nih.gov/pubmed/39469916

249.Yonguc, T., et al. Randomized, controlled trial of fesoterodine fumarate for overactive bladder in Parkinson’s disease. World J Urol, 2020. 38: 2013. 
https://www.ncbi.nlm.nih.gov/pubmed/31642953

250.Konstantinidis, C., et al. Efficacy of fesoterodine fumarate (8 mg) in neurogenic detrusor overactivity due to spinal cord lesion or multiple sclerosis: A prospective study. Neurourol Urodyn, 2021. 40: 2026. 
https://www.ncbi.nlm.nih.gov/pubmed/34498773

251.Walter, M., et al. Fesoterodine Ameliorates Autonomic Dysreflexia While Improving Lower Urinary Tract Function and Urinary Incontinence-Related Quality of Life in Individuals With Spinal Cord Injury: A Prospective Phase IIa Study. J Neurotrauma, 2023. 40: 1020. 
https://www.ncbi.nlm.nih.gov/pubmed/36178342

252.Sakakibara, R., et al. Imidafenacin on bladder and cognitive function in neurologic OAB patients. Clin Auton Res, 2013. 23: 189. 
https://www.ncbi.nlm.nih.gov/pubmed/23820664

253.Sugiyama, H., et al. Effect of imidafenacin on the urodynamic parameters of patients with indwelling bladder catheters due to spinal cord injury. Spinal Cord, 2017. 55: 187. 
https://www.ncbi.nlm.nih.gov/pubmed/27897185

254.Stohrer, M., et al. Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity. Spinal Cord, 2013. 51: 419. 
https://www.ncbi.nlm.nih.gov/pubmed/23338657

255.Schroder, A., et al. Efficacy, safety, and tolerability of intravesically administered 0.1% oxybutynin hydrochloride solution in adult patients with neurogenic bladder: A randomized, prospective, controlled multi-center trial. Neurourol Urodyn, 2016. 35: 582. 
https://www.ncbi.nlm.nih.gov/pubmed/25754454

256.Dmochowski, R.R., et al. Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta-analysis. Neurourol Urodyn, 2021. 40: 28. 
https://www.ncbi.nlm.nih.gov/pubmed/33098213

257.Trbovich, M., et al. The treatment of neurogenic lower urinary tract dysfunction in persons with spinal cord injury: An open label, pilot study of anticholinergic agent vs. mirabegron to evaluate cognitive impact and efficacy. Spinal Cord Ser Cases, 2021. 7: 50. 
https://www.ncbi.nlm.nih.gov/pubmed/34112758

258.El Helou, E., et al. The use of mirabegron in neurogenic bladder: a systematic review. World J Urol, 2020. 38: 2435. 
https://www.ncbi.nlm.nih.gov/pubmed/31802206

259.Glykas, I., et al. B3 agonists or anticholinergics in the treatment of the lower urinary tract dysfunction in patients with multiple sclerosis?-A randomized study. World J Urol, 2021. 39: 3049. 
https://www.ncbi.nlm.nih.gov/pubmed/33386947

260.Krhut, J., et al. Efficacy and safety of mirabegron for the treatment of neurogenic detrusor overactivity-Prospective, randomized, double-blind, placebo-controlled study. Neurourol Urodyn, 2018. 37: 2226. 
https://www.ncbi.nlm.nih.gov/pubmed/29603781

261.Akkoc, Y. Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review. Spinal Cord, 2022. 60: 854. 
https://www.ncbi.nlm.nih.gov/pubmed/36085413

262.Krhut, J., et al. Cardiovascular safety of mirabegron in individuals treated for spinal cord injury- or multiple sclerosis-induced neurogenic detrusor overactivity. Int Urol Nephrol, 2021. 53: 1089. 
https://www.ncbi.nlm.nih.gov/pubmed/33417146

263.Chen, S.F., et al. Therapeutic efficacy of low-dose (25 mg) mirabegron therapy for patients with mild to moderate overactive bladder symptoms due to central nervous system diseases. Low Urin Tract Symptoms, 2019. 11: O53. 
https://www.ncbi.nlm.nih.gov/pubmed/29380517

264.Cho, S.Y., et al. Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson’s disease: A double-blind, randomized placebo-controlled trial (Parkinson’s Disease Overactive bladder Mirabegron, PaDoMi Study). Neurourol Urodyn, 2021. 40: 286. 
https://www.ncbi.nlm.nih.gov/pubmed/33389776

265.Abraham, D.S., et al. Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease. Parkinsonism Relat Disord, 2023. 115: 105822. 
https://www.ncbi.nlm.nih.gov/pubmed/37713748

266.Cheng, B., et al. The efficacy and safety of medication for treating overactive bladder in patients with Parkinson’s disease: a meta-analysis and systematic review of randomized double-blind placebo-controlled trials. Int Urogynecol J, 2023. 34: 2207. 
https://www.ncbi.nlm.nih.gov/pubmed/37052644

267.Elkhashab, M.M., et al. Safety and efficacy of beta-3 adrenergic agonists in treating neurogenic lower urinary tract dysfunction: A systematic review and meta-analysis. Investig Clin Urol, 2024. 65: 217. 
https://www.ncbi.nlm.nih.gov/pubmed/38714512

268.Matsuda, K., et al. Urodynamic effect of vibegron on neurogenic lower urinary tract dysfunction in individuals with spinal cord injury: A retrospective study. Spinal Cord, 2022. 60: 716. 
https://www.ncbi.nlm.nih.gov/pubmed/35177800

269.Mukai, S., et al. Comparison of the 3-Year Continuation Rate and Discontinuation Factors Between Vibegron and Mirabegron in Patients With Overactive Bladder: A Retrospective Follow-Up Study in a Rehabilitation Hospital in Japan. Low Urin Tract Symptoms, 2025. 17: e70001. 
https://www.ncbi.nlm.nih.gov/pubmed/39632546

270.Hajebrahimi, S., et al. Efficacy and safety of desmopressin in nocturia and nocturnal polyuria control of neurological patients: A systematic review and meta-analysis. Neurourol Urodyn, 2024. 43: 167. 
https://www.ncbi.nlm.nih.gov/pubmed/37746880

271.Zachariou, A., et al. Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron. Can J Urol, 2017. 24: 9107. 
https://www.ncbi.nlm.nih.gov/pubmed/29260636

272.Abo Youssef, N., et al. Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis. BJU Int, 2017. 119: 515. 
https://www.ncbi.nlm.nih.gov/pubmed/28058780

273.Torri Clerici, V., et al. Nabiximols oromucosal spray in patients with multiple sclerosis-related bladder dysfunction: A prospective study. Mult Scler Relat Disord, 2023. 74: 104711. 
https://www.ncbi.nlm.nih.gov/pubmed/37062198

274.Francomano, D., et al. Effects of daily tadalafil on lower urinary tract symptoms in young men with multiple sclerosis and erectile dysfunction: a pilot study. J Endocrinol Invest, 2017. 40: 275. 
https://www.ncbi.nlm.nih.gov/pubmed/27752863

275.Barendrecht, M.M., et al. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int, 2007. 99: 749. 
https://www.ncbi.nlm.nih.gov/pubmed/17233798

276.Apostolidis, A. Taming the cannabinoids: new potential in the pharmacologic control of lower urinary tract dysfunction. Eur Urol, 2012. 61: 107. 
https://www.ncbi.nlm.nih.gov/pubmed/21996529

277.Gratzke, C., et al. Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats. Eur Urol, 2010. 57: 1093. 
https://www.ncbi.nlm.nih.gov/pubmed/20207474

278.Abrams, P., et al. Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury. J Urol, 2003. 170: 1242. 
https://www.ncbi.nlm.nih.gov/pubmed/14501734

279.Gomes, C.M., et al. Neurological status predicts response to alpha-blockers in men with voiding dysfunction and Parkinson’s disease. Clinics (Sao Paulo), 2014. 69: 817. 
https://www.ncbi.nlm.nih.gov/pubmed/25627993

280.Moon, K.H., et al. A 12-Week, Open Label, Multi-Center Study to Evaluate the Clinical Efficacy and Safety of Silodosin on Voiding Dysfunction in Patients with Neurogenic Bladder. Low Urin Tract Symptoms, 2015. 7: 27. 
https://www.ncbi.nlm.nih.gov/pubmed/26663648

281.Schneider, M.P., et al. Alpha-blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS). Neurourol Urodyn, 2019. 38: 1482. 
https://www.ncbi.nlm.nih.gov/pubmed/31099113

282.Sung, H.H., et al. Efficacy and Safety of Naftopidil in Patients With Neurogenic Lower Urinary Tract Dysfunction: An 8-Week, Active-Controlled, Stratified-Randomized, Double-Blind, Double-Dummy, Parallel Group, Noninferiority, Multicenter Design. Int Neurourol J, 2020. 24: 163. 
https://www.ncbi.nlm.nih.gov/pubmed/32615679

283.Guttmann, L., et al. The value of intermittent catheterisation in the early management of traumatic paraplegia and tetraplegia. Paraplegia, 1966. 4: 63. 
https://www.ncbi.nlm.nih.gov/pubmed/5969402

284.Lapides, J., et al. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol, 1972. 107: 458. 
https://www.ncbi.nlm.nih.gov/pubmed/5010715

285.Elliott, C.S., et al. Validation of Upper Extremity Motor Function as a Key Predictor of Bladder Management After Spinal Cord Injury. Arch Phys Med Rehabil, 2019. 100: 1939. 
https://www.ncbi.nlm.nih.gov/pubmed/31348899

286.Jamison, J., et al. Catheter policies for management of long term voiding problems in adults with neurogenic bladder disorders. Cochrane Database Syst Rev, 2013. 2013: CD004375. 
https://www.ncbi.nlm.nih.gov/pubmed/24249436

287.Sekido, N., et al. Impact of urinary catheters including reusable catheters on quality of life and work productivity in persons with spinal cord lesion. Sci Rep, 2024. 14: 24383. 
https://www.ncbi.nlm.nih.gov/pubmed/39420068

288.Prieto-Fingerhut, T., et al. A study comparing sterile and nonsterile urethral catheterization in patients with spinal cord injury. Rehabil Nurs, 1997. 22: 299. 
https://www.ncbi.nlm.nih.gov/pubmed/9416190

289.Corona, L.E., et al. Intermittent catheterization and urinary tract infection in multiple sclerosis patients. Can J Urol, 2020. 27: 10294. 
https://www.ncbi.nlm.nih.gov/pubmed/32861254

290.Crescenze, I.M., et al. Predictors of low urinary quality of life in spinal cord injury patients on clean intermittent catheterization. Neurourol Urodyn, 2019. 38: 1332. 
https://www.ncbi.nlm.nih.gov/pubmed/30912199

291.Neumeier, V., et al. Indwelling catheter vs intermittent catheterization: is there a difference in UTI susceptibility? BMC Infect Dis, 2023. 23: 507. 
https://www.ncbi.nlm.nih.gov/pubmed/37533010

292.Patel, D.P., et al. Reasons for cessation of clean intermittent catheterization after spinal cord injury: Results from the Neurogenic Bladder Research Group spinal cord injury registry. Neurourol Urodyn, 2020. 39: 211. 
https://www.ncbi.nlm.nih.gov/pubmed/31578784

293.Ali, S., et al. Hydrophilic catheters for intermittent catheterization and occurrence of urinary tract infections. A retrospective comparative study in patients with spinal cord Injury. BMC Urol, 2024. 24: 122. 
https://www.ncbi.nlm.nih.gov/pubmed/38867233

294.Goetz, L.L., et al. International Spinal Cord Injury Urinary Tract Infection Basic Data Set. Spinal Cord, 2013. 51: 700. 
https://www.ncbi.nlm.nih.gov/pubmed/23896666

295.Bakke, A., et al. Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study. Br J Urol, 1997. 79: 85. 
https://www.ncbi.nlm.nih.gov/pubmed/9043503

296.Günther, M., et al. Auswirkungen des aseptischen intermittierenden Katheterismus auf die männliche Harnröhre. Der Urologe B, 2001. 41: 359. 
http://dx.doi.org/10.1007/s001310170044

297.Kurze, I., et al. Intermittierender Einmal-Katheterismus und Prävention von Harnwegsinfekten bei Patienten mit neurogener Harnblasenfunktionsstörung - „Best practice“. Eine Übersicht. Aktuelle Neurologie, 2015. 42: 515. 
http://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0035-1564127

298.Waller, L., et al. Clean intermittent catheterization in spinal cord injury patients: long-term followup of a hydrophilic low friction technique. J Urol, 1995. 153: 345. 
https://www.ncbi.nlm.nih.gov/pubmed/7815579

299.Wyndaele, J.J. Complications of intermittent catheterization: their prevention and treatment. Spinal Cord, 2002. 40: 536. 
https://www.ncbi.nlm.nih.gov/pubmed/12235537

300.L, D.E.P., et al. Intermittent self-catheterization training and effects on treatment adherence and infection. Eur J Phys Rehabil Med, 2023. 59: 782. 
https://www.ncbi.nlm.nih.gov/pubmed/37750862

301.Woodbury, M.G., et al. Intermittent catheterization practices following spinal cord injury: a national survey. Can J Urol, 2008. 15: 4065. 
https://www.ncbi.nlm.nih.gov/pubmed/18570710

302.Bennett, C.J., et al. Comparison of bladder management complication outcomes in female spinal cord injury patients. J Urol, 1995. 153: 1458. 
https://www.ncbi.nlm.nih.gov/pubmed/7714965

303.Chao, R., et al. Fate of upper urinary tracts in patients with indwelling catheters after spinal cord injury. Urology, 1993. 42: 259. 
https://www.ncbi.nlm.nih.gov/pubmed/8379025

304.Larsen, L.D., et al. Retrospective analysis of urologic complications in male patients with spinal cord injury managed with and without indwelling urinary catheters. Urology, 1997. 50: 418. 
https://www.ncbi.nlm.nih.gov/pubmed/9301708

305.Mitsui, T., et al. Is suprapubic cystostomy an optimal urinary management in high quadriplegics?. A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Urol, 2000. 38: 434. 
https://www.ncbi.nlm.nih.gov/pubmed/11025382

306.Weld, K.J., et al. Effect of bladder management on urological complications in spinal cord injured patients. J Urol, 2000. 163: 768. 
https://www.ncbi.nlm.nih.gov/pubmed/10687973

307.Weld, K.J., et al. Influences on renal function in chronic spinal cord injured patients. J Urol, 2000. 164: 1490. 
https://www.ncbi.nlm.nih.gov/pubmed/11025689

308.Lavelle, R.S., et al. Quality of life after suprapubic catheter placement in patients with neurogenic bladder conditions. Neurourol Urodyn, 2016. 35: 831. 
https://www.ncbi.nlm.nih.gov/pubmed/26197729

309.Hird, A.E., et al. Association between chronic bladder catheterisation and bladder cancer incidence and mortality: a population-based retrospective cohort study in Ontario, Canada. BMJ Open, 2021. 11: e050728. 
https://www.ncbi.nlm.nih.gov/pubmed/34475180

310.Hollingsworth, J.M., et al. Determining the noninfectious complications of indwelling urethral catheters: a systematic review and meta-analysis. Ann Intern Med, 2013. 159: 401. 
https://www.ncbi.nlm.nih.gov/pubmed/24042368

311.Cao, W., et al. Clamping Catheter Versus Free Drainage for Patients With Neurogenic Bladder With Indwelling Urinary Catheter: A Meta-Analysis. Biol Res Nurs, 2025. 27: 359. 
https://www.ncbi.nlm.nih.gov/pubmed/39809550

312.Ismail, S., et al. Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: A systematic review. Neurourol Urodyn, 2018. 37: 1386. 
https://www.ncbi.nlm.nih.gov/pubmed/29168217

313.Wu, X., et al. Efficacy and safety of transcutaneous electrical nerve stimulation combined with clean intermittent catheterization for neurogenic bladder dysfunction in patients with cauda equina syndrome. Int Urol Nephrol, 2025. 57: 3227. 
https://www.ncbi.nlm.nih.gov/pubmed/40252204

314.Hao, F., et al. Acceptance and the influencing factors towards intermittent self-catheterisation among patients with neurogenic lower urinary tract dysfunction in China: a multicentre cross-sectional study. BMJ Open, 2024. 14: e090047. 
https://www.ncbi.nlm.nih.gov/pubmed/39653569

315.Shen, S.H., et al. Intravesical oxybutynin therapy for patients with neurogenic detrusor overactivity: a systematic review and meta-analysis. Int Urol Nephrol, 2022. 54: 737. 
https://www.ncbi.nlm.nih.gov/pubmed/35226282

316.Wang, Q., et al. Efficiency and Safety of Noninvasive and Intravesical Therapy for Adult Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. Drugs, 2025. 85: 677. 
https://www.ncbi.nlm.nih.gov/pubmed/40167970

317.Buyse, G., et al. Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J Urol, 1998. 160: 892. 
https://www.ncbi.nlm.nih.gov/pubmed/9720583

318.Di Stasi, S.M., et al. Intravesical oxybutynin: mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin. J Urol, 2001. 166: 2232. 
https://www.ncbi.nlm.nih.gov/pubmed/11696741

319.Giannantoni, A., et al. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. J Urol, 2004. 172: 240. 
https://www.ncbi.nlm.nih.gov/pubmed/15201783

320.Kim, J.H., et al. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial. J Spinal Cord Med, 2003. 26: 358. 
https://www.ncbi.nlm.nih.gov/pubmed/14992337

321.Phe, V., et al. Desmopressin for treating nocturia in patients with multiple sclerosis: A systematic review: A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS). Neurourol Urodyn, 2019. 38: 563. 
https://www.ncbi.nlm.nih.gov/pubmed/30653737

322.Del Popolo, G., et al. Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre. Eur Urol, 2008. 53: 1013. 
https://www.ncbi.nlm.nih.gov/pubmed/17950989

323.Reitz, A., et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol, 2004. 45: 510. 
https://www.ncbi.nlm.nih.gov/pubmed/15041117

324.Yuan, H., et al. Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis. Int Neurourol J, 2017. 21: 53. 
https://www.ncbi.nlm.nih.gov/pubmed/28361515

325.Cheng, T., et al. Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One, 2016. 11: e0159307. 
https://www.ncbi.nlm.nih.gov/pubmed/27463810

326.Wagle Shukla, A., et al. Botulinum Toxin Therapy for Parkinson’s Disease. Semin Neurol, 2017. 37: 193. 
https://www.ncbi.nlm.nih.gov/pubmed/28511260

327.Wu, S.J., et al. Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis. Ren Fail, 2019. 41: 937. 
https://www.ncbi.nlm.nih.gov/pubmed/31599184

328.Chen, S.F., et al. Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury. Toxins (Basel), 2022. 14. 
https://www.ncbi.nlm.nih.gov/pubmed/35051012

329.Baron, M., et al. Long-Term Discontinuation of Botulinum Toxin A Intradetrusor Injections for Neurogenic Detrusor Overactivity: A Multicenter Study. J Urol, 2019. 201: 769. 
https://www.ncbi.nlm.nih.gov/pubmed/30359679

330.Leitner, L., et al. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned. Eur Urol, 2016. 70: 522. 
https://www.ncbi.nlm.nih.gov/pubmed/27106070

331.Koschorke, M., et al. Intradetrusor onabotulinumtoxinA injections for refractory neurogenic detrusor overactivity incontinence: do we need urodynamic investigation for outcome assessment? BJU Int, 2017. 120: 848. 
https://www.ncbi.nlm.nih.gov/pubmed/28771936

332.Ginsberg, D., et al. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J Urol, 2012. 187: 2131. 
https://www.ncbi.nlm.nih.gov/pubmed/22503020

333.Grosse, J., et al. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol, 2005. 47: 653. 
https://www.ncbi.nlm.nih.gov/pubmed/15826758

334.Rovner, E., et al. Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment. J Urol, 2016. 196: 801. 
https://www.ncbi.nlm.nih.gov/pubmed/27091236

335.Ni, J., et al. Is repeat Botulinum Toxin A injection valuable for neurogenic detrusor overactivity-A systematic review and meta-analysis. Neurourol Urodyn, 2018. 37: 542. 
https://www.ncbi.nlm.nih.gov/pubmed/28745818

336.Chui, W., et al. Long-term follow-up of intradetrusor botulinum toxin utilisation: A comparison of patients with multiple sclerosis and idiopathic overactive bladder. BJUI Compass, 2025. 6: e479. 
https://www.ncbi.nlm.nih.gov/pubmed/39877585

337.Michel, F., et al. Botulinum Toxin Type A Injection After Failure of Augmentation Enterocystoplasty Performed for Neurogenic Detrusor Overactivity: Preliminary Results of a Salvage Strategy. The ENTEROTOX Study. Urology, 2019. 129: 43. 
https://www.ncbi.nlm.nih.gov/pubmed/30926380

338.Toia, B., et al. The efficacy of onabotulinumtoxinA in patients with previous failed augmentation cystoplasty: Cohort series and literature review. Neurourol Urodyn, 2020. 39: 1831. 
https://www.ncbi.nlm.nih.gov/pubmed/32572987

339.Giannantoni, A., et al. IncobotulinumtoxinA versus onabotulinumtoxinA intradetrusor injections in patients with neurogenic detrusor overactivity incontinence: a double-blind, randomized, non-inferiority trial. Minerva Urol Nephrol, 2022. 74: 625. 
https://www.ncbi.nlm.nih.gov/pubmed/33769020

340.Cruz, F., et al. Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison. J Med Econ, 2023. 26: 200. 
https://www.ncbi.nlm.nih.gov/pubmed/36647624

341.Bottet, F., et al. Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed. Neurourol Urodyn, 2018. 37: 291. 
https://www.ncbi.nlm.nih.gov/pubmed/28431196

342.Yu, P.H., et al. Adverse Effects of Intravesical OnabotulinumtoxinA Injection in Patients with Idiopathic Overactive Bladder or Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. Toxins (Basel), 2024. 16: 343. 
https://www.ncbi.nlm.nih.gov/pubmed/39195753

343.Tullman, M., et al. Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS. Neurology, 2018. 91: e657. 
https://www.ncbi.nlm.nih.gov/pubmed/30030330

344.Cui, Y., et al. Trigonal-Sparing vs. Trigonal-Involved OnabotulinumtoxinA Injection for the Treatment of Overactive Bladder: A Systematic Review and Meta-Analysis. Front Neurol, 2021. 12: 651635. 
https://www.ncbi.nlm.nih.gov/pubmed/34690904

345.Tyagi, P., et al. Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive Bladder. J Urol, 2017. 197: 982. 
https://www.ncbi.nlm.nih.gov/pubmed/27871929

346.Young, M.J., et al. Another Therapeutic Role for Intravesical Botulinum Toxin: Patients with Long-stay Catheters and Refractory Bladder Pain and Catheter Bypass Leakage. Eur Urol Focus, 2020. 6: 339. 
https://www.ncbi.nlm.nih.gov/pubmed/30392867

347.Wu, S.Y., et al. Satisfaction with Surgical Procedures and Bladder Management of Chronic Spinal Cord Injured Patients with Voiding Dysfunction Who Desire Spontaneous Voiding. J Pers Med, 2022. 12. 
https://www.ncbi.nlm.nih.gov/pubmed/36294890

348.Lee, C.L., et al. Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction. Toxins (Basel), 2022. 14. 
https://www.ncbi.nlm.nih.gov/pubmed/35051007

349.Popat, S., et al. Sphincteric Injection of Botulinum Toxin for Urinary Retention due to Neurogenic Bladder. Current Bladder Dysfunction Reports, 2022. 17: 179. 
https://doi.org/10.1007/s11884-022-00657-4

350.Haggart, R., et al. External Urethral Sphincter Botulinum Toxin Injection to Treat Pseudodysynergia in Patients With Cerebral Palsy. Urology, 2024. 186: 48. 
https://www.ncbi.nlm.nih.gov/pubmed/38387511

351.Utomo, E., et al. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction. Cochrane Database Syst Rev, 2014. 2014: CD004927. 
https://www.ncbi.nlm.nih.gov/pubmed/24859260

352.Bennett, J.K., et al. Collagen injections for intrinsic sphincter deficiency in the neuropathic urethra. Paraplegia, 1995. 33: 697. 
https://www.ncbi.nlm.nih.gov/pubmed/8927407

353.Block, C.A., et al. Long-term efficacy of periurethral collagen injection for the treatment of urinary incontinence secondary to myelomeningocele. J Urol, 2003. 169: 327. 
https://www.ncbi.nlm.nih.gov/pubmed/12478183

354.Schurch, B., et al. Intraurethral sphincter prosthesis to treat hyporeflexic bladders in women: does it work? BJU Int, 1999. 84: 789. 
https://www.ncbi.nlm.nih.gov/pubmed/10532973

355.Antoniadis, G., et al. Urethral bulking agents and pelvic floor muscle training for the treatment of stress urinary incontinence in female patients with multiple sclerosis. Bladder (San Franc), 2024. 11: e21200028. 
https://www.ncbi.nlm.nih.gov/pubmed/39944513

356.Reuvers, S.H.M., et al. Heterogeneity in reporting on urinary outcome and cure after surgical interventions for stress urinary incontinence in adult neuro-urological patients: A systematic review. Neurourol Urodyn, 2018. 37: 554. 
https://www.ncbi.nlm.nih.gov/pubmed/28792081

357.Cardozo, L., et al., Incontinence 7th Edition ICI-ICS. Vol. 7th 2023, Bristol, UK.

358.Barthold, J.S., et al. Results of the rectus fascial sling and wrap procedures for the treatment of neurogenic sphincteric incontinence. J Urol, 1999. 161: 272. 
https://www.ncbi.nlm.nih.gov/pubmed/10037423

359.Musco, S., et al. Efficacy and Safety of Surgical Treatments for Neurogenic Stress Urinary Incontinence in Adults: A Systematic Review. Eur Urol Focus, 2022. 8: 1090. 
https://www.ncbi.nlm.nih.gov/pubmed/34509413

360.Sarrazin, C., et al. Synthetic Mid-urethral Sling for the Treatment of Urinary Incontinence in Women With Neurogenic Lower Urinary Tract Dysfunction: A Multicentric Retrospective Study. J Urol, 2023. 209: 1176. 
https://www.ncbi.nlm.nih.gov/pubmed/36812396

361.Pannek, J., et al. Management of stress urinary incontinence in female patients with spinal cord injury by autologous fascial sling: time for a revival? Spinal Cord Ser Cases, 2022. 8: 57. 
https://www.ncbi.nlm.nih.gov/pubmed/35610208

362.Deytrikh, A., et al. Autologous fascial slings for stress urinary incontinence in patients with neuropathic bladder. Spinal Cord Ser Cases, 2022. 8: 25. 
https://www.ncbi.nlm.nih.gov/pubmed/35210403

363.Light, J.K., et al. Use of the artificial urinary sphincter in spinal cord injury patients. J Urol, 1983. 130: 1127. 
https://www.ncbi.nlm.nih.gov/pubmed/6644893

364.Farag, F., et al. Surgical treatment of neurogenic stress urinary incontinence: A systematic review of quality assessment and surgical outcomes. Neurourol Urodyn, 2016. 35: 21. 
https://www.ncbi.nlm.nih.gov/pubmed/25327633

365.Kim, S.P., et al. Long-term durability and functional outcomes among patients with artificial urinary sphincters: a 10-year retrospective review from the University of Michigan. J Urol, 2008. 179: 1912. 
https://www.ncbi.nlm.nih.gov/pubmed/18353376

366.Wang, R., et al. Long-term outcomes after primary failures of artificial urinary sphincter implantation. Urology, 2012. 79: 922. 
https://www.ncbi.nlm.nih.gov/pubmed/22305763

367.Guillot-Tantay, C., et al. [Male neurogenic stress urinary incontinence treated by artificial urinary sphincter AMS 800 (Boston Scientific, Boston, USA): Very long-term results (>25 years)]. Prog Urol, 2018. 28: 39. 
https://www.ncbi.nlm.nih.gov/pubmed/29102375

368.Phe, V., et al. Stress urinary incontinence in female neurological patients: long-term functional outcomes after artificial urinary sphincter (AMS 800(TM) ) implantation. Neurourol Urodyn, 2017. 36: 764. 
https://www.ncbi.nlm.nih.gov/pubmed/27080729

369.Chartier-Kastler, E., et al. Outcomes of robot-assisted urinary sphincter implantation for male neurogenic urinary incontinence. BJU Int, 2022. 129: 243. 
https://www.ncbi.nlm.nih.gov/pubmed/34174147

370.Scott, K.A., et al. Use of Artificial Urinary Sphincter and Slings to Manage Neurogenic Bladder Following Spinal Cord Injury-Is It Safe? Current Bladder Dysfunction Reports 2017. 12: 311. 
https://link.springer.com/article/10.1007/s11884-017-0449-9

371.Tricard, T., et al. Outcomes of artificial urinary sphincter in female with neurological stress urinary incontinence: a long-term follow-up. World J Urol, 2021. 39: 157. 
https://www.ncbi.nlm.nih.gov/pubmed/32052128

372.Gasmi, A., et al. Long-term outcomes of artificial urinary sphincter in female patients with spina bifida. Neurourol Urodyn, 2021. 40: 412. 
https://www.ncbi.nlm.nih.gov/pubmed/33197064

373.Ruggiero, M., et al. Single center experience and long-term outcomes of implantable devices ACT and Pro-ACT (Uromedica, Irvin, CA, USA) - Adjustable continence Therapy for treatment of stress urinary incontinence. Prog Urol, 2023. 33: 96. 
https://www.ncbi.nlm.nih.gov/pubmed/36572628

374.Demeestere, A., et al. Adjustable continence therapy (ACT(R)) balloons to treat neurogenic and non-neurogenic female urinary incontinence. Neurourol Urodyn, 2022. 41: 313. 
https://www.ncbi.nlm.nih.gov/pubmed/34633672

375.Ronzi, Y., et al. Neurogenic stress urinary incontinence: is there a place for Adjustable Continence Therapy (ACT and ProACT, Uromedica, Plymouth, MN, USA)? A retrospective multicenter study. Spinal Cord, 2019. 57: 388. 
https://www.ncbi.nlm.nih.gov/pubmed/30626977

376.Donnahoo, K.K., et al. The Young-Dees-Leadbetter bladder neck repair for neurogenic incontinence. J Urol, 1999. 161: 1946. 
https://www.ncbi.nlm.nih.gov/pubmed/10332478

377.Kropp, K.A., et al. Urethral lengthening and reimplantation for neurogenic incontinence in children. J Urol, 1986. 135: 533. 
https://www.ncbi.nlm.nih.gov/pubmed/3944902

378.Salle, J.L., et al. Urethral lengthening with anterior bladder wall flap (Pippi Salle procedure): modifications and extended indications of the technique. J Urol, 1997. 158: 585. 
https://www.ncbi.nlm.nih.gov/pubmed/9224369

379.Rawashdeh, Y.F., et al. International Children’s Continence Society’s recommendations for therapeutic intervention in congenital neuropathic bladder and bowel dysfunction in children. Neurourol Urodyn, 2012. 31: 615. 
https://www.ncbi.nlm.nih.gov/pubmed/22532368

380.Noordhoff, T.C., et al. Surgical Management of Anatomic Bladder Outlet Obstruction in Males with Neurogenic Bladder Dysfunction: A Systematic Review. Eur Urol Focus, 2019. 5: 875. 
https://www.ncbi.nlm.nih.gov/pubmed/29551557

381.Charalampous, I., et al. Does Surgical Treatment for Benign Prostate Enlargement (BPE)-Related Bladder Outlet Obstruction (BOO) Benefit Patients with Central Nervous System Diseases? A Systematic Review. J Clin Med, 2024. 13: 5846. 
https://www.ncbi.nlm.nih.gov/pubmed/39407906

382.Cornejo-Davila, V., et al. Incidence of Urethral Stricture in Patients With Spinal Cord Injury Treated With Clean Intermittent Self-Catheterization. Urology, 2017. 99: 260. 
https://www.ncbi.nlm.nih.gov/pubmed/27566143

383.Perkash, I. Ablation of urethral strictures using contact chisel crystal firing neodymium:YAG laser. J Urol, 1997. 157: 809. 
https://www.ncbi.nlm.nih.gov/pubmed/9072572

384.Gonzalez-Espinosa, C., et al. Diagnosis and treatment of urethral stricture in men with neurogenic lower urinary tract dysfunction: A systematic review. Neurourol Urodyn, 2022. 41: 1248. 
https://www.ncbi.nlm.nih.gov/pubmed/35686544

385.Schurch, B., et al. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol, 2005. 174: 196. 
https://www.ncbi.nlm.nih.gov/pubmed/15947626

386.Madersbacher, H., et al. Twelve o’clock sphincterotomy: technique, indications, results. (Abbreviated report). Urol Int, 1975. 30: 75. 
https://www.ncbi.nlm.nih.gov/pubmed/1118951

387.Perkash, I. Laser sphincterotomy and ablation of the prostate using a sapphire chisel contact tip firing neodymium:YAG laser. J Urol, 1994. 152: 2020. 
https://www.ncbi.nlm.nih.gov/pubmed/7966667

388.Noll, F., et al. Transurethral sphincterotomy in quadriplegic patients: long-term-follow-up. Neurourol Urodyn, 1995. 14: 351. 
https://www.ncbi.nlm.nih.gov/pubmed/7581471

389.Chancellor, M.B., et al. Prospective comparison of external sphincter balloon dilatation and prosthesis placement with external sphincterotomy in spinal cord injured men. Arch Phys Med Rehabil, 1994. 75: 297. 
https://www.ncbi.nlm.nih.gov/pubmed/8129583

390.Derry, F., et al. Audit of bladder neck resection in spinal cord injured patients. Spinal Cord, 1998. 36: 345. 
https://www.ncbi.nlm.nih.gov/pubmed/9601115

391.Chang, T.L., et al. Surgical outcome of male patients with chronic central nervous system disorders and voiding dysfunction due to bladder outlet obstruction. Int Urol Nephrol, 2022. 54: 2511. 
https://www.ncbi.nlm.nih.gov/pubmed/35821368

392.Chancellor, M.B., et al. Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia. J Urol, 1999. 161: 1545. 
https://www.ncbi.nlm.nih.gov/pubmed/10210393

393.Seoane-Rodriguez, S., et al. Long-term follow-up study of intraurethral stents in spinal cord injured patients with detrusor-sphincter dyssynergia. Spinal Cord, 2007. 45: 621. 
https://www.ncbi.nlm.nih.gov/pubmed/17211463

394.Gajewski, J.B., et al. Removal of UroLume endoprosthesis: experience of the North American Study Group for detrusor-sphincter dyssynergia application. J Urol, 2000. 163: 773. 
https://www.ncbi.nlm.nih.gov/pubmed/10687974

395.Wilson, T.S., et al. UroLume stents: lessons learned. J Urol, 2002. 167: 2477. 
https://www.ncbi.nlm.nih.gov/pubmed/11992061

396.Abdul-Rahman, A., et al. A 20-year follow-up of the mesh wallstent in the treatment of detrusor external sphincter dyssynergia in patients with spinal cord injury. BJU Int, 2010. 106: 1510. 
https://www.ncbi.nlm.nih.gov/pubmed/20500511

397.Pannek, J., et al. Clinical usefulness of the memokath stent as a second-line procedure after sphincterotomy failure. J Endourol, 2011. 25: 335. 
https://www.ncbi.nlm.nih.gov/pubmed/20977372

398.Polguer, T., et al. [Treatment of detrusor-striated sphincter dyssynergia with permanent nitinol urethral stent: results after a minimum follow-up of 2 years]. Prog Urol, 2012. 22: 1058. 
https://www.ncbi.nlm.nih.gov/pubmed/23182120

399.van der Merwe, A., et al. Outcome of dual flange metallic urethral stents in the treatment of neuropathic bladder dysfunction after spinal cord injury. J Endourol, 2012. 26: 1210. 
https://www.ncbi.nlm.nih.gov/pubmed/22519741

400.Brindley, G.S. An implant to empty the bladder or close the urethra. J Neurol Neurosurg Psychiatry, 1977. 40: 358. 
https://www.ncbi.nlm.nih.gov/pubmed/406364

401.Krasmik, D., et al. Urodynamic results, clinical efficacy, and complication rates of sacral intradural deafferentation and sacral anterior root stimulation in patients with neurogenic lower urinary tract dysfunction resulting from complete spinal cord injury. Neurourol Urodyn, 2014. 33: 1202. 
https://www.ncbi.nlm.nih.gov/pubmed/24038405

402.Benard, A., et al. Comparative cost-effectiveness analysis of sacral anterior root stimulation for rehabilitation of bladder dysfunction in spinal cord injured patients. Neurosurgery, 2013. 73: 600. 
https://www.ncbi.nlm.nih.gov/pubmed/23787880

403.Martens, F.M., et al. Quality of life in complete spinal cord injury patients with a Brindley bladder stimulator compared to a matched control group. Neurourol Urodyn, 2011. 30: 551. 
https://www.ncbi.nlm.nih.gov/pubmed/21328472

404.Guiho, T., et al. Sacral Anterior Root Stimulation and Visceral Function Outcomes in Spinal Cord Injury-A Systematic Review of the Literature Over Four Decades. World Neurosurg, 2022. 157: 218. 
https://www.ncbi.nlm.nih.gov/pubmed/34547528

405.Krebs, J., et al. Long-term course of sacral anterior root stimulation in spinal cord injured individuals: The fate of the detrusor. Neurourol Urodyn, 2017. 36: 1596. 
https://www.ncbi.nlm.nih.gov/pubmed/27778371

406.Wei, Z., et al. Effectiveness and safety of sacral neuromodulation for neurogenic bladder. Neurol Res, 2023. 45: 520. 
https://www.ncbi.nlm.nih.gov/pubmed/36683144

407.Sun, P., et al. A Meta-Analysis on the Efficacy and Safety of Sacral Neuromodulation for Neurogenic Bladder or Bowel Dysfunction. Neuromodulation, 2025. 28: 727. 
https://www.ncbi.nlm.nih.gov/pubmed/39641704

408.Krebs, J., et al. Charcot arthropathy of the spine in spinal cord injured individuals with sacral deafferentation and anterior root stimulator implantation. Neurourol Urodyn, 2016. 35: 241. 
https://www.ncbi.nlm.nih.gov/pubmed/25524388

409.Nagib, A., et al. Successful control of selective anterior sacral rhizotomy for treatment of spastic bladder and ureteric reflux in paraplegics. Med Serv J Can, 1966. 22: 576. 
https://www.ncbi.nlm.nih.gov/pubmed/5966992

410.Schneidau, T., et al. Selective sacral rhizotomy for the management of neurogenic bladders in spina bifida patients: long-term followup. J Urol, 1995. 154: 766. 
https://www.ncbi.nlm.nih.gov/pubmed/7609174

411.Young, B., et al. Percutaneous sacral rhizotomy for neurogenic detrusor hyperreflexia. J Neurosurg, 1980. 53: 85. 
https://www.ncbi.nlm.nih.gov/pubmed/7411212

412.Koldewijn, E.L., et al. Bladder compliance after posterior sacral root rhizotomies and anterior sacral root stimulation. J Urol, 1994. 151: 955. 
https://www.ncbi.nlm.nih.gov/pubmed/8126835

413.Singh, G., et al. Intravesical oxybutynin in patients with posterior rhizotomies and sacral anterior root stimulators. Neurourol Urodyn, 1995. 14: 65. 
https://www.ncbi.nlm.nih.gov/pubmed/7742851

414.Van Kerrebroeck, P.E., et al. Results of the treatment of neurogenic bladder dysfunction in spinal cord injury by sacral posterior root rhizotomy and anterior sacral root stimulation. J Urol, 1996. 155: 1378. 
https://www.ncbi.nlm.nih.gov/pubmed/8632580

415.Kutzenberger, J. Surgical therapy of neurogenic detrusor overactivity (hyperreflexia) in paraplegic patients by sacral deafferentation and implant driven micturition by sacral anterior root stimulation: methods, indications, results, complications, and future prospects. Acta Neurochir Suppl, 2007. 97: 333. 
https://www.ncbi.nlm.nih.gov/pubmed/17691394

416.Bhadra, N., et al. Selective suppression of sphincter activation during sacral anterior nerve root stimulation. Neurourol Urodyn, 2002. 21: 55. 
https://www.ncbi.nlm.nih.gov/pubmed/11835425

417.Kirkham, A.P., et al. Neuromodulation through sacral nerve roots 2 to 4 with a Finetech-Brindley sacral posterior and anterior root stimulator. Spinal Cord, 2002. 40: 272. 
https://www.ncbi.nlm.nih.gov/pubmed/12037708

418.Schumacher, S., et al. Extradural cold block for selective neurostimulation of the bladder: development of a new technique. J Urol, 1999. 161: 950. 
https://www.ncbi.nlm.nih.gov/pubmed/10022732

419.Liechti, M.D., et al. Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction. NEJM Evid, 2022. 1: EVIDoa2200071. 
https://www.ncbi.nlm.nih.gov/pubmed/38319849

420.Greenberg, D.R., et al. Sacral Nerve Stimulation in Parkinson’s Disease Patients With Overactive Bladder Symptoms. Urology, 2020. 144: 99. 
https://www.ncbi.nlm.nih.gov/pubmed/32681915

421.Kessler, T.M., et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol, 2010. 58: 865. 
https://www.ncbi.nlm.nih.gov/pubmed/20934242

422.van Ophoven, A., et al. Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years’ Experience and Future Directions. Adv Ther, 2021. 38: 1987. 
https://www.ncbi.nlm.nih.gov/pubmed/33713279

423.Trump, T., et al. Outcomes of Sacral Neuromodulation and Intradetrusor Onabotulinum Toxin in the Management of Stroke Associated Urinary Incontinence. Int Neurourol J, 2025. 29: 10. 
https://www.ncbi.nlm.nih.gov/pubmed/40211833

424.Guitynavard, F., et al. Percutaneous posterior tibial nerve stimulation (PTNS) for lower urinary tract symptoms (LUTSs) treatment in patients with multiple sclerosis (MS): A systematic review and meta-analysis. Mult Scler Relat Disord, 2022. 58: 103392. 
https://www.ncbi.nlm.nih.gov/pubmed/35216773

425.Pericolini, M., et al. Cortical, Spinal, Sacral, and Peripheral Neuromodulations as Therapeutic Approaches for the Treatment of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients: A Review. Neuromodulation, 2022. 25: 1065. 
https://www.ncbi.nlm.nih.gov/pubmed/34496454

426.Pattanshetti, S., et al. Transcutaneous Electrical Nerve Stimulation in Management of Neurogenic bladder Secondary to Spina Bifida. J Indian Assoc Pediatr Surg, 2022. 27: 570. 
https://www.ncbi.nlm.nih.gov/pubmed/36530811

427.Jorg, E., et al. Deep brain stimulation effects on lower urinary tract function: Systematic review and meta-analysis. Parkinsonism Relat Disord, 2020. 79: 65. 
https://www.ncbi.nlm.nih.gov/pubmed/32889502

428.Sartori, A.M., et al. Effects of Deep Brain Stimulation on Lower Urinary Tract Function in Neurological Patients. Eur Urol Focus, 2022. 8: 1775. 
https://www.ncbi.nlm.nih.gov/pubmed/35662503

429.Gao, L., et al. Impact of deep brain stimulation on urogenital function in Parkinson’s disease: a systematic review and meta-analysis. Front Neurol, 2024. 15: 1397344. 
https://www.ncbi.nlm.nih.gov/pubmed/39026583

430.Zhang, Y.H., et al. Enveloping the bladder with displacement of flap of the rectus abdominis muscle for the treatment of neurogenic bladder. J Urol, 1990. 144: 1194. 
https://www.ncbi.nlm.nih.gov/pubmed/2146404

431.Stenzl, A., et al. Restoration of voluntary emptying of the bladder by transplantation of innervated free skeletal muscle. Lancet, 1998. 351: 1483. 
https://www.ncbi.nlm.nih.gov/pubmed/9605805

432.Gakis, G., et al. Functional detrusor myoplasty for bladder acontractility: long-term results. J Urol, 2011. 185: 593. 
https://www.ncbi.nlm.nih.gov/pubmed/21168866

433.Ninkovic, M., et al. The latissimus dorsi detrusor myoplasty for functional treatment of bladder acontractility. Clin Plast Surg, 2012. 39: 507. 
https://www.ncbi.nlm.nih.gov/pubmed/23036300

434.Duel, B.P., et al. Alternative techniques for augmentation cystoplasty. J Urol, 1998. 159: 998. 
https://www.ncbi.nlm.nih.gov/pubmed/9474216

435.Snow, B.W., et al. Bladder autoaugmentation. Urol Clin North Am, 1996. 23: 323. 
https://www.ncbi.nlm.nih.gov/pubmed/8659030

436.Stohrer, M., et al. Bladder auto-augmentation--an alternative for enterocystoplasty: preliminary results. Neurourol Urodyn, 1995. 14: 11. 
https://www.ncbi.nlm.nih.gov/pubmed/7742844

437.Stohrer, M., et al. Bladder autoaugmentation in adult patients with neurogenic voiding dysfunction. Spinal Cord, 1997. 35: 456. 
https://www.ncbi.nlm.nih.gov/pubmed/9232751

438.Vainrib, M., et al. Differences in urodynamic study variables in adult patients with neurogenic bladder and myelomeningocele before and after augmentation enterocystoplasty. Neurourol Urodyn, 2013. 32: 250. 
https://www.ncbi.nlm.nih.gov/pubmed/22965686

439.Krebs, J., et al. Functional outcome of supratrigonal cystectomy and augmentation ileocystoplasty in adult patients with refractory neurogenic lower urinary tract dysfunction. Neurourol Urodyn, 2016. 35: 260. 
https://www.ncbi.nlm.nih.gov/pubmed/25524480

440.Hoen, L., et al. Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: A systematic review. Neurourol Urodyn, 2017. 36: 1685. 
https://www.ncbi.nlm.nih.gov/pubmed/28169459

441.Trojan, K.C., et al. Improvement of bladder function after bladder augmentation surgery: a report of 26 years of clinical experience. Pediatr Surg Int, 2022. 38: 941. 
https://www.ncbi.nlm.nih.gov/pubmed/35348841

442.Romero-Maroto, J., et al. Long-term effectiveness and safety of bladder augmentation in spina bifida patients. Neurourol Urodyn, 2021. 40: 1576. 
https://www.ncbi.nlm.nih.gov/pubmed/34082472

443.Wang, Z., et al. Effectiveness and Complications of Augmentation Cystoplasty with or without Nonrefluxing Ureteral Reimplantation in Patients with Bladder Dysfunction: A Single Center 11-Year Experience. J Urol, 2018. 199: 200. 
https://www.ncbi.nlm.nih.gov/pubmed/28743527

444.Myers, J.B., et al. The effects of augmentation cystoplasty and botulinum toxin injection on patient-reported bladder function and quality of life among individuals with spinal cord injury performing clean intermittent catheterization. Neurourol Urodyn, 2019. 38: 285. 
https://www.ncbi.nlm.nih.gov/pubmed/30375055

445.Mitsui, T., et al. Preoperative renal scar as a risk factor of postoperative metabolic acidosis following ileocystoplasty in patients with neurogenic bladder. Spinal Cord, 2014. 52: 292. 
https://www.ncbi.nlm.nih.gov/pubmed/24469144

446.Balanca, A., et al. Long-term clinical and urodynamic effectiveness of augmentation ileocystoplasty with supra-trigonal cystectomy in individuals with spinal cord injury. World J Urol, 2022. 40: 2121. 
https://www.ncbi.nlm.nih.gov/pubmed/35680652

447.Perrouin-Verbe, M.A., et al. Long-term functional outcomes of augmentation cystoplasty in adult spina bifida patients: A single-center experience in a multidisciplinary team. Neurourol Urodyn, 2019. 38: 330. 
https://www.ncbi.nlm.nih.gov/pubmed/30350892

448.Frainey, B.T., et al. Complications of Pediatric Bladder Reconstruction in the Adult Patient. Current Bladder Dysfunction Reports, 2020. 15: 173. 
https://doi.org/10.1007/s11884-020-00584-2

449.Moreno, J.G., et al. Improved quality of life and sexuality with continent urinary diversion in quadriplegic women with umbilical stoma. Arch Phys Med Rehabil, 1995. 76: 758. 
https://www.ncbi.nlm.nih.gov/pubmed/7632132

450.Peterson, A.C., et al. Urinary diversion in patients with spinal cord injury in the United States. Urology, 2012. 80: 1247. 
https://www.ncbi.nlm.nih.gov/pubmed/23206770

451.Sylora, J.A., et al. Intermittent self-catheterization by quadriplegic patients via a catheterizable Mitrofanoff channel. J Urol, 1997. 157: 48. 
https://www.ncbi.nlm.nih.gov/pubmed/8976213

452.Van Savage, J.G., et al. Transverse retubularized sigmoidovesicostomy continent urinary diversion to the umbilicus. J Urol, 2001. 166: 644. 
https://www.ncbi.nlm.nih.gov/pubmed/11458110

453.Vanni, A.J., et al. Ileovesicostomy for the neurogenic bladder patient: outcome and cost comparison of open and robotic assisted techniques. Urology, 2011. 77: 1375. 
https://www.ncbi.nlm.nih.gov/pubmed/21146864

454.Wiener, J.S., et al. Bladder augmentation versus urinary diversion in patients with spina bifida in the United States. J Urol, 2011. 186: 161. 
https://www.ncbi.nlm.nih.gov/pubmed/21575969

455.Cheng, P.J., et al. Contemporary multicenter outcomes of continent cutaneous ileocecocystoplasty in the adult population over a 10-year period: A Neurogenic Bladder Research Group study. Neurourol Urodyn, 2020. 39: 1771. 
https://www.ncbi.nlm.nih.gov/pubmed/32506711

456.Phe, V., et al. Continent catheterizable tubes/stomas in adult neuro-urological patients: A systematic review. Neurourol Urodyn, 2017. 36: 1711. 
https://www.ncbi.nlm.nih.gov/pubmed/28139848

457.Gharbi, M., et al. Quality of life in neurogenic patients based on different bladder management methods: A review. Prog Urol, 2022. 32: 784. 
https://www.ncbi.nlm.nih.gov/pubmed/35941011

458.Atan, A., et al. Advantages and risks of ileovesicostomy for the management of neuropathic bladder. Urology, 1999. 54: 636. 
https://www.ncbi.nlm.nih.gov/pubmed/10510920

459.Cass, A.S., et al. A 22-year followup of ileal conduits in children with a neurogenic bladder. J Urol, 1984. 132: 529. 
https://www.ncbi.nlm.nih.gov/pubmed/6471190

460.Hald, T., et al. Vesicostomy--an alternative urine diversion operation. Long term results. Scand J Urol Nephrol, 1978. 12: 227. 
https://www.ncbi.nlm.nih.gov/pubmed/725543

461.Schwartz, S.L., et al. Incontinent ileo-vesicostomy urinary diversion in the treatment of lower urinary tract dysfunction. J Urol, 1994. 152: 99. 
https://www.ncbi.nlm.nih.gov/pubmed/8201699

462.Sakhri, R., et al. [Laparoscopic cystectomy and ileal conduit urinary diversion for neurogenic bladders and related conditions. Morbidity and better quality of life]. Prog Urol, 2015. 25: 342. 
https://www.ncbi.nlm.nih.gov/pubmed/25726693

463.Akakpo, W., et al. Outcomes of ileal conduit urinary diversion in patients with multiple sclerosis. Neurourol Urodyn, 2020. 39: 771. 
https://www.ncbi.nlm.nih.gov/pubmed/31951678

464.Mazouin, C., et al. Robot-Assisted Cystectomy and Ileal Conduit for Neurogenic Bladder: Comparison of Extracorporeal vs Intracorporeal Urinary Diversion. J Endourol, 2021. 35: 1350. 
https://www.ncbi.nlm.nih.gov/pubmed/33499755

465.Haudebert, C., et al. Cystectomy and ileal conduit for neurogenic bladder: Comparison of the open, laparoscopic and robotic approaches. Neurourol Urodyn, 2022. 41: 601. 
https://www.ncbi.nlm.nih.gov/pubmed/34962653

466.Chkir, S., et al. Non-continent Urinary Diversion (Ileal Conduit) as Salvage Therapy in Patients With Refractory Lower Urinary Tract Dysfunctions due to Multiple Sclerosis: Results of a National Cohort From the French Association of Urology (AFU) Neurourology Committee and the French-speaking Neurourology Study Group (GENULF). Urology, 2022. 168: 216. 
https://www.ncbi.nlm.nih.gov/pubmed/35768028

467.Beirnaert, J., et al. Robotic versus open cystectomy with ileal conduit for the management of neurogenic bladder: a comparative study. World J Urol, 2022. 40: 2963. 
https://www.ncbi.nlm.nih.gov/pubmed/36280600

468.Herschorn, S., et al. Urinary undiversion in adults with myelodysplasia: long-term followup. J Urol, 1994. 152: 329. 
https://www.ncbi.nlm.nih.gov/pubmed/8015064

469.Sartori, A.M., et al. Definitions of Urinary Tract Infection Used in Interventional Studies Involving Neurourological Patients-A Systematic Review. Eur Urol Focus, 2022. 8: 1386. 
https://www.ncbi.nlm.nih.gov/pubmed/34404618

470.Mukai, S., et al. Retrospective study for risk factors for febrile UTI in spinal cord injury patients with routine concomitant intermittent catheterization in outpatient settings. Spinal Cord, 2016. 54: 69. 
https://www.ncbi.nlm.nih.gov/pubmed/26458969

471.Everett, R.G., et al. Factors associated with recurrent urinary tract infections in spinal cord injured patients who use intermittent catheterization. Can J Urol, 2021. 28: 10920. 
https://www.ncbi.nlm.nih.gov/pubmed/34895397

472.Vasudeva, P., et al. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored. Neurourol Urodyn, 2014. 33: 95. 
https://www.ncbi.nlm.nih.gov/pubmed/23460489

473.Ruijuan, Z., et al. Effects of Catheter Tracking Management on Urinary Tract Function and Infection Rates in Patients With Spinal Cord Injury. Altern Ther Health Med, 2023. 29: 104. 
https://www.ncbi.nlm.nih.gov/pubmed/36634314

474.Welk, B., et al. Differences in the incidence of urinary tract infections between neurogenic and non-neurogenic bladder dysfunction individuals performing intermittent catheterization. Neurourol Urodyn, 2022. 41: 1002. 
https://www.ncbi.nlm.nih.gov/pubmed/35332597

475.Zhou, L., et al. Early warning model construction and validation for urinary tract infection in patients with neurogenic lower urinary tract dysfunction (NLUTD): a retrospective study. PeerJ, 2022. 10: e13388. 
https://www.ncbi.nlm.nih.gov/pubmed/35539015

476.Lenherr, S.M., et al. Glycemic Control and Urinary Tract Infections in Women with Type 1 Diabetes: Results from the DCCT/EDIC. J Urol, 2016. 196: 1129. 
https://www.ncbi.nlm.nih.gov/pubmed/27131462

477.Bakke, A., et al. Bacteriuria in patients treated with clean intermittent catheterization. Scand J Infect Dis, 1991. 23: 577. 
https://www.ncbi.nlm.nih.gov/pubmed/1767253

478.Waites, K.B., et al. Epidemiology and risk factors for urinary tract infection following spinal cord injury. Arch Phys Med Rehabil, 1993. 74: 691. 
https://www.ncbi.nlm.nih.gov/pubmed/8328888

479.Nicolle, L.E., et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis, 2005. 40: 643. 
https://www.ncbi.nlm.nih.gov/pubmed/15714408

480.Wang, W., et al. A risk prediction model of urinary tract infections for patients with neurogenic bladder. Int J Neurosci, 2021. 131: 31. 
https://www.ncbi.nlm.nih.gov/pubmed/32075472

481.Wirth, M., et al. Retrospective Cohort Study of Patient-Reported Urinary Tract Infection Signs and Symptoms Among Individuals With Neurogenic Bladder. Am J Phys Med Rehabil, 2023. 102: 663. 
https://www.ncbi.nlm.nih.gov/pubmed/36927768

482.Pannek, J. Treatment of urinary tract infection in persons with spinal cord injury: guidelines, evidence, and clinical practice. A questionnaire-based survey and review of the literature. J Spinal Cord Med, 2011. 34: 11. 
https://www.ncbi.nlm.nih.gov/pubmed/21528621

483.Alavinia, S.M., et al. Enhancing quality practice for prevention and diagnosis of urinary tract infection during inpatient spinal cord rehabilitation. J Spinal Cord Med, 2017. 40: 803. 
https://www.ncbi.nlm.nih.gov/pubmed/28872426

484.Deville, W.L., et al. The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. BMC Urol, 2004. 4: 4. 
https://www.ncbi.nlm.nih.gov/pubmed/15175113

485.Hoffman, J.M., et al. Nitrite and leukocyte dipstick testing for urinary tract infection in individuals with spinal cord injury. J Spinal Cord Med, 2004. 27: 128. 
https://www.ncbi.nlm.nih.gov/pubmed/15162883

486.Biering-Sorensen, F., et al. Urinary tract infections in patients with spinal cord lesions: treatment and prevention. Drugs, 2001. 61: 1275. 
https://www.ncbi.nlm.nih.gov/pubmed/11511022

487.Everaert, K., et al. Urinary tract infections in spinal cord injury: prevention and treatment guidelines. Acta Clin Belg, 2009. 64: 335. 
https://www.ncbi.nlm.nih.gov/pubmed/19810421

488.Clark, R., et al. The ability of prior urinary cultures results to predict future culture results in neurogenic bladder patients. Neurourol Urodyn, 2018. 37: 2645. 
https://www.ncbi.nlm.nih.gov/pubmed/29799144

489.Pannek, J., et al. Treatment of Complicated Urinary Tract Infections in Individuals with Chronic Neurogenic Lower Urinary Tract Dysfunction: Are Antibiotics Mandatory? Urol Int, 2018. 100: 434. 
https://www.ncbi.nlm.nih.gov/pubmed/29649808

490.Del Popolo, G., et al. Recurrent bacterial symptomatic cystitis: A pilot study on a new natural option for treatment. Arch Ital Urol Androl, 2018. 90: 101. 
https://www.ncbi.nlm.nih.gov/pubmed/29974728

491.Jia, C., et al. Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury. Spinal Cord, 2013. 51: 487. 
https://www.ncbi.nlm.nih.gov/pubmed/23357928

492.Gallien, P., et al. Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial. Mult Scler, 2014. 20: 1252. 
https://www.ncbi.nlm.nih.gov/pubmed/24402038

493.Toh, S.L., et al. Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial. Spinal Cord, 2019. 57: 550. 
https://www.ncbi.nlm.nih.gov/pubmed/30814670

494.Lee, B.S., et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev, 2012. 10: CD003265. 
https://www.ncbi.nlm.nih.gov/pubmed/23076896

495.Günther, M., et al. Harnwegsinfektprophylaxe. Urinansäuerung mittels L-Methionin bei neurogener Blasenfunktionsstörung. Urologe B, 2002. 42: 218. 
https://www.iqwig.de/download/a04-02_abschlussbericht_l-methionin_bei_neurogenen_blasenstoerungen.pdf

496.Hachen, H.J. Oral immunotherapy in paraplegic patients with chronic urinary tract infections: a double-blind, placebo-controlled trial. J Urol, 1990. 143: 759. 
https://www.ncbi.nlm.nih.gov/pubmed/2179584

497.Krebs, J., et al. Effects of oral immunomodulation therapy on urinary tract infections in individuals with chronic spinal cord injury-A retrospective cohort study. Neurourol Urodyn, 2019. 38: 346. 
https://www.ncbi.nlm.nih.gov/pubmed/30350886

498.Welk, B., et al. Efficacy of antibiotic prophylaxis among intermittent catheter users with different neurologic diseases: A secondary analysis of the AnTIC Trial. Continence, 2022. 1: 100004. 
https://www.sciencedirect.com/science/article/pii/S2772973722000029

499.Dinh, A., et al. Weekly Sequential Antibioprophylaxis for Recurrent Urinary Tract Infections Among Patients With Neurogenic Bladder: A Randomized Controlled Trial. Clin Infect Dis, 2020. 71: 3128. 
https://www.ncbi.nlm.nih.gov/pubmed/31867616

500.Darouiche, R.O., et al. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology, 2011. 78: 341. 
https://www.ncbi.nlm.nih.gov/pubmed/21683991

501.Pannek, J., et al. Usefulness of classical homeopathy for the prophylaxis of recurrent urinary tract infections in individuals with chronic neurogenic lower urinary tract dysfunction. J Spinal Cord Med, 2019. 42: 453. 
https://www.ncbi.nlm.nih.gov/pubmed/29485355

502.Moussa, M., et al. Bladder irrigation with povidone-iodine prevent recurrent urinary tract infections in neurogenic bladder patients on clean intermittent catheterization. Neurourol Urodyn, 2021. 40: 672. 
https://www.ncbi.nlm.nih.gov/pubmed/33476092

503.Tate, D.G., et al. The Effects of Gentamicin Intravesical Bladder Instillations on Decreasing Urinary Tract Infections After Spinal Cord Injury and Disease. Neurourol Urodyn, 2025. 44: 829. 
https://www.ncbi.nlm.nih.gov/pubmed/40095724

504.den Hoedt, S., et al. Bladder irrigation with tap water to reduce antibiotic use for urinary tract infections in catheter users. BJU Int, 2025. 135: 286. 
https://www.ncbi.nlm.nih.gov/pubmed/39414620

505.Ziadeh, T., et al. Bladder instillation for urinary tract infection prevention in neurogenic bladder patients practicing clean intermittent catheterization: A systematic review. Urologia, 2022. 89: 261. 
https://www.ncbi.nlm.nih.gov/pubmed/34612750

506.Pannek, J., et al. Usefulness of classical homoeopathy for the prevention of urinary tract infections in patients with neurogenic bladder dysfunction: A case series. . Indian J Res Homoeopathy, 2014. 8: 31. 
https://www.ijrh.org/journal/vol8/iss1/6/

507.Rees, P.M., et al. Sexual function in men and women with neurological disorders. Lancet, 2007. 369: 512. 
https://www.ncbi.nlm.nih.gov/pubmed/17292771

508.Lombardi, G., et al. Management of sexual dysfunction due to central nervous system disorders: a systematic review. BJU Int, 2015. 115 Suppl 6: 47. 
https://www.ncbi.nlm.nih.gov/pubmed/25599613

509.Salonia, A., et al., EAU Guidelines on sexual and reproductive health, in EAU Guidelines. Edn. presented at the EAU Annual Congress Milan. March 2023. 
https://uroweb.org/guidelines/sexual-and-reproductive-health

510.Hentzen, C., et al. Approach and management to patients with neurological disorders reporting sexual dysfunction. Lancet Neurol, 2022. 21: 551. 
https://www.ncbi.nlm.nih.gov/pubmed/35405093

511.Foley, F.W., Sexuality, in Multiple Sclerosis: A Guide for Families K. RC., Editor. 2006, Demos Medical Publishing: New York, USA.

512.Annon, J.S., PLISSIT Therapy in Handbook of Innovative Psychotherapies. , R. Corsini, Editor. 1981, Wiley & Sons: New York.

513.Fragala, E., et al. Relationship between urodynamic findings and sexual function in multiple sclerosis patients with lower urinary tract dysfunction. Eur J Neurol, 2015. 22: 485. 
https://www.ncbi.nlm.nih.gov/pubmed/25410608

514.Game, X., et al. Sexual function of young women with myelomeningocele. J Pediatr Urol, 2014. 10: 418. 
https://www.ncbi.nlm.nih.gov/pubmed/23992838

515.Ozkan, H., et al. Prevalence, Trajectory, and Factors Associated With Patient-Reported Nonmotor Outcomes After Stroke: A Systematic Review and Meta-Analysis. JAMA Netw Open, 2025. 8: e2457447. 
https://www.ncbi.nlm.nih.gov/pubmed/39982730

516.Chen, L., et al. Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis. Eur Urol, 2015. 68: 674. 
https://www.ncbi.nlm.nih.gov/pubmed/25817916

517.Fowler, C.J., et al. A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J Neurol Neurosurg Psychiatry, 2005. 76: 700. 
https://www.ncbi.nlm.nih.gov/pubmed/15834030

518.Safarinejad, M.R. Expression of Concern: Evaluation of the Safety and Efficacy of Sildenafil Citrate for Erectile Dysfunction in Men With Multiple Sclerosis: A Double-Blind, Placebo Controlled, Randomized Study. J Urol, 2023: 101097JU0000000000003114. 
https://www.ncbi.nlm.nih.gov/pubmed/36626341

519.Streur, C.S., et al. Sexual Function of Men and Women With Spina Bifida: A Scoping Literature Review. Sex Med Rev, 2021. 9: 244. 
https://www.ncbi.nlm.nih.gov/pubmed/33608247

520.Lombardi, G., et al. Ten years of phosphodiesterase type 5 inhibitors in spinal cord injured patients. J Sex Med, 2009. 6: 1248. 
https://www.ncbi.nlm.nih.gov/pubmed/19210710

521.Lombardi, G., et al. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature. J Sex Med, 2012. 9: 970. 
https://www.ncbi.nlm.nih.gov/pubmed/22304626

522.Cardenas, D.D., et al. Two phase 3, multicenter, randomized, placebo-controlled clinical trials of fampridine-SR for treatment of spasticity in chronic spinal cord injury. Spinal Cord, 2014. 52: 70. 
https://www.ncbi.nlm.nih.gov/pubmed/24216616

523.Strebel, R.T., et al. Apomorphine sublingual as primary or secondary treatment for erectile dysfunction in patients with spinal cord injury. BJU Int, 2004. 93: 100. 
https://www.ncbi.nlm.nih.gov/pubmed/14678378

524.Pohanka, M., et al. The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson’s disease induced by pergolide: evidence from the results of an open, prospective, one-year trial. Parkinsonism Relat Disord, 2005. 11: 509. 
https://www.ncbi.nlm.nih.gov/pubmed/15994112

525.Chancellor, M.B., et al. Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury. Urology, 1994. 43: 365. 
https://www.ncbi.nlm.nih.gov/pubmed/8134992

526.Cookson, M.S., et al. Long-term results with vacuum constriction device. J Urol, 1993. 149: 290. 
https://www.ncbi.nlm.nih.gov/pubmed/8426404

527.Denil, J., et al. Vacuum erection device in spinal cord injured men: patient and partner satisfaction. Arch Phys Med Rehabil, 1996. 77: 750. 
https://www.ncbi.nlm.nih.gov/pubmed/8702367

528.Levine, L.A. External devices for treatment of erectile dysfunction. Endocrine, 2004. 23: 157. 
https://www.ncbi.nlm.nih.gov/pubmed/15146095

529.Levine, L.A., et al. Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am, 2001. 28: 335. 
https://www.ncbi.nlm.nih.gov/pubmed/11402585

530.Bella, A.J., et al. Intracavernous pharmacotherapy for erectile dysfunction. Endocrine, 2004. 23: 149. 
https://www.ncbi.nlm.nih.gov/pubmed/15146094

531.Bodner, D.R., et al. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury. J Urol, 1987. 138: 310. 
https://www.ncbi.nlm.nih.gov/pubmed/3599245

532.Deforge, D., et al. Male erectile dysfunction following spinal cord injury: a systematic review. Spinal Cord, 2006. 44: 465. 
https://www.ncbi.nlm.nih.gov/pubmed/16317419

533.Dinsmore, W.W., et al. Treating men with predominantly nonpsychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate in a novel auto-injector system: a multicentre double-blind placebo-controlled study. BJU Int, 1999. 83: 274. 
https://www.ncbi.nlm.nih.gov/pubmed/10233493

534.Hirsch, I.H., et al. Use of intracavernous injection of prostaglandin E1 for neuropathic erectile dysfunction. Paraplegia, 1994. 32: 661. 
https://www.ncbi.nlm.nih.gov/pubmed/7831071

535.Kapoor, V.K., et al. Intracavernous papaverine for impotence in spinal cord injured patients. Paraplegia, 1993. 31: 675. 
https://www.ncbi.nlm.nih.gov/pubmed/8259331

536.Vidal, J., et al. Intracavernous pharmacotherapy for management of erectile dysfunction in multiple sclerosis patients. Rev Neurol, 1995. 23: 269. 
https://www.ncbi.nlm.nih.gov/pubmed/7497173

537.Bodner, D.R., et al. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury. Urology, 1999. 53: 199. 
https://www.ncbi.nlm.nih.gov/pubmed/9886612

538.Gross, A.J., et al. Penile prostheses in paraplegic men. Br J Urol, 1996. 78: 262. 
https://www.ncbi.nlm.nih.gov/pubmed/8813925

539.Kimoto, Y., et al. Penile prostheses for the management of the neuropathic bladder and sexual dysfunction in spinal cord injury patients: long term follow up. Paraplegia, 1994. 32: 336. 
https://www.ncbi.nlm.nih.gov/pubmed/8058351

540.Zermann, D.H., et al. Penile prosthetic surgery in neurologically impaired patients: long-term followup. J Urol, 2006. 175: 1041. 
https://www.ncbi.nlm.nih.gov/pubmed/16469612

541.Fode, M., et al. Male sexual dysfunction and infertility associated with neurological disorders. Asian J Androl, 2012. 14: 61. 
https://www.ncbi.nlm.nih.gov/pubmed/22138899

542.Lim, T.C., et al. A simple technique to prevent retrograde ejaculation during assisted ejaculation. Paraplegia, 1994. 32: 142. 
https://www.ncbi.nlm.nih.gov/pubmed/8008416

543.Philippon, M., et al. Successful pregnancies and healthy live births using frozen-thawed sperm retrieved by a new modified Hotchkiss procedure in males with retrograde ejaculation: first case series. Basic Clin Androl, 2015. 25: 5. 
https://www.ncbi.nlm.nih.gov/pubmed/26034605

544.Arafa, M.M., et al. Prostatic massage: a simple method of semen retrieval in men with spinal cord injury. Int J Androl, 2007. 30: 170. 
https://www.ncbi.nlm.nih.gov/pubmed/17298549

545.Kolettis, P.N., et al. Fertility outcomes after electroejaculation in men with spinal cord injury. Fertil Steril, 2002. 78: 429. 
https://www.ncbi.nlm.nih.gov/pubmed/12137889

546.Chehensse, C., et al. The spinal control of ejaculation revisited: a systematic review and meta-analysis of anejaculation in spinal cord injured patients. Hum Reprod Update, 2013. 19: 507. 
https://www.ncbi.nlm.nih.gov/pubmed/23820516

547.Beretta, G., et al. Reproductive aspects in spinal cord injured males. Paraplegia, 1989. 27: 113. 
https://www.ncbi.nlm.nih.gov/pubmed/2717193

548.Brackett, N.L., et al. Application of 2 vibrators salvages ejaculatory failures to 1 vibrator during penile vibratory stimulation in men with spinal cord injuries. J Urol, 2007. 177: 660. 
https://www.ncbi.nlm.nih.gov/pubmed/17222653

549.Sonksen, J., et al. Ejaculation induced by penile vibratory stimulation in men with spinal cord injuries. The importance of the vibratory amplitude. Paraplegia, 1994. 32: 651. 
https://www.ncbi.nlm.nih.gov/pubmed/7831070

550.Claydon, V.E., et al. Cardiovascular responses to vibrostimulation for sperm retrieval in men with spinal cord injury. J Spinal Cord Med, 2006. 29: 207. 
https://www.ncbi.nlm.nih.gov/pubmed/16859224

551.Ekland, M.B., et al. Incidence of autonomic dysreflexia and silent autonomic dysreflexia in men with spinal cord injury undergoing sperm retrieval: implications for clinical practice. J Spinal Cord Med, 2008. 31: 33. 
https://www.ncbi.nlm.nih.gov/pubmed/18533409

552.Soler, J.M., et al. Midodrine improves ejaculation in spinal cord injured men. J Urol, 2007. 178: 2082. 
https://www.ncbi.nlm.nih.gov/pubmed/17869290

553.Pecori, C., et al. Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. BMC Neurol, 2014. 14: 114. 
https://www.ncbi.nlm.nih.gov/pubmed/24884599

554.Brackett, N.L., et al. Treatment of infertility in men with spinal cord injury. Nat Rev Urol, 2010. 7: 162. 
https://www.ncbi.nlm.nih.gov/pubmed/20157304

555.Raviv, G., et al. Testicular sperm retrieval and intra cytoplasmic sperm injection provide favorable outcome in spinal cord injury patients, failing conservative reproductive treatment. Spinal Cord, 2013. 51: 642. 
https://www.ncbi.nlm.nih.gov/pubmed/23689394

556.Schatte, E.C., et al. Treatment of infertility due to anejaculation in the male with electroejaculation and intracytoplasmic sperm injection. J Urol, 2000. 163: 1717. 
https://www.ncbi.nlm.nih.gov/pubmed/10799167

557.Shieh, J.Y., et al. A protocol of electroejaculation and systematic assisted reproductive technology achieved high efficiency and efficacy for pregnancy for anejaculatory men with spinal cord injury. Arch Phys Med Rehabil, 2003. 84: 535. 
https://www.ncbi.nlm.nih.gov/pubmed/12690592

558.Taylor, Z., et al. Contribution of the assisted reproductive technologies to fertility in males suffering spinal cord injury. Aust N Z J Obstet Gynaecol, 1999. 39: 84. 
https://www.ncbi.nlm.nih.gov/pubmed/10099757

559.Rutkowski, S.B., et al. The influence of bladder management on fertility in spinal cord injured males. Paraplegia, 1995. 33: 263. 
https://www.ncbi.nlm.nih.gov/pubmed/7630651

560.Hamed, S.A., et al. Seminal fluid analysis and testicular volume in adults with epilepsy receiving valproate. J Clin Neurosci, 2015. 22: 508. 
https://www.ncbi.nlm.nih.gov/pubmed/25636832

561.Ohl, D.A., et al. Electroejaculation versus vibratory stimulation in spinal cord injured men: sperm quality and patient preference. J Urol, 1997. 157: 2147. 
https://www.ncbi.nlm.nih.gov/pubmed/9146603

562.Brackett, N.L., et al. Semen quality of spinal cord injured men is better when obtained by vibratory stimulation versus electroejaculation. J Urol, 1997. 157: 151. 
https://www.ncbi.nlm.nih.gov/pubmed/8976239

563.Brackett, N.L., et al. Semen retrieval in men with spinal cord injury is improved by interrupting current delivery during electroejaculation. J Urol, 2002. 167: 201. 
https://www.ncbi.nlm.nih.gov/pubmed/11743305

564.DeForge, D., et al. Fertility following spinal cord injury: a systematic review. Spinal Cord, 2005. 43: 693. 
https://www.ncbi.nlm.nih.gov/pubmed/15951744

565.Ferreiro-Velasco, M.E., et al. Sexual issues in a sample of women with spinal cord injury. Spinal Cord, 2005. 43: 51. 
https://www.ncbi.nlm.nih.gov/pubmed/15303115

566.Kreuter, M., et al. Sexuality and sexual life in women with spinal cord injury: a controlled study. J Rehabil Med, 2008. 40: 61. 
https://www.ncbi.nlm.nih.gov/pubmed/18176739

567.Kreuter, M., et al. Sexual adjustment and quality of relationship in spinal paraplegia: a controlled study. Arch Phys Med Rehabil, 1996. 77: 541. 
https://www.ncbi.nlm.nih.gov/pubmed/8831469

568.Kessler, T.M., et al. Sexual dysfunction in multiple sclerosis. Expert Rev Neurother, 2009. 9: 341. 
https://www.ncbi.nlm.nih.gov/pubmed/19271943

569.Lew-Starowicz, M., et al. Prevalence of Sexual Dysfunctions Among Women with Multiple Sclerosis. Sex Disabil, 2013. 31: 141. 
https://www.ncbi.nlm.nih.gov/pubmed/23704801

570.Motta, G.L., et al. Sexuality of Female Spina Bifida Patients: Predictors of a Satisfactory Sexual Function. Rev Bras Ginecol Obstet, 2021. 43: 467. 
https://www.ncbi.nlm.nih.gov/pubmed/34318472

571.Motta, G.L., et al. The impact of neurogenic bladder bowel dysfunction in the sexuality of female spina bifida patients. J Pediatr Urol, 2021. 17: 288 e1. 
https://www.ncbi.nlm.nih.gov/pubmed/33546979

572.Alexander, M., et al. Spinal cord injuries and orgasm: a review. J Sex Marital Ther, 2008. 34: 308. 
https://www.ncbi.nlm.nih.gov/pubmed/18576233

573.McAlonan, S. Improving sexual rehabilitation services: the patient’s perspective. Am J Occup Ther, 1996. 50: 826. 
https://www.ncbi.nlm.nih.gov/pubmed/8947375

574.Schopp, L.H., et al. Impact of comprehensive gynecologic services on health maintenance behaviours among women with spinal cord injury. Disabil Rehabil, 2002. 24: 899. 
https://www.ncbi.nlm.nih.gov/pubmed/12519485

575.Vikan, J.K., et al. Sexual Satisfaction and Associated Biopsychosocial Factors in Stroke Patients Admitted to Specialized Cognitive Rehabilitation. Sex Med, 2021. 9: 100424. 
https://www.ncbi.nlm.nih.gov/pubmed/34474266

576.Reitz, A., et al. Impact of spinal cord injury on sexual health and quality of life. Int J Impot Res, 2004. 16: 167. 
https://www.ncbi.nlm.nih.gov/pubmed/14973522

577.Harrison, J., et al. Factors associated with sexual functioning in women following spinal cord injury. Paraplegia, 1995. 33: 687. 
https://www.ncbi.nlm.nih.gov/pubmed/8927405

578.Westgren, N., et al. Sexuality in women with traumatic spinal cord injury. Acta Obstet Gynecol Scand, 1997. 76: 977. 
https://www.ncbi.nlm.nih.gov/pubmed/9435740

579.Fruhauf, S., et al. Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis. Arch Sex Behav, 2013. 42: 915. 
https://www.ncbi.nlm.nih.gov/pubmed/23559141

580.Sipski, M.L., et al. Physiologic parameters associated with sexual arousal in women with incomplete spinal cord injuries. Arch Phys Med Rehabil, 1997. 78: 305. 
https://www.ncbi.nlm.nih.gov/pubmed/9084355

581.Sipski, M.L., et al. Sexual arousal and orgasm in women: effects of spinal cord injury. Ann Neurol, 2001. 49: 35. 
https://www.ncbi.nlm.nih.gov/pubmed/11198294

582.Sukumaran, S.C., et al. Polytherapy increases the risk of infertility in women with epilepsy. Neurology, 2010. 75: 1351. 
https://www.ncbi.nlm.nih.gov/pubmed/20938026

583.Axel, S.J. Spinal cord injured women’s concerns: menstruation and pregnancy. Rehabil Nurs, 1982. 7: 10. 
https://www.ncbi.nlm.nih.gov/pubmed/6921826

584.Jackson, A.B., et al. A multicenter study of women’s self-reported reproductive health after spinal cord injury. Arch Phys Med Rehabil, 1999. 80: 1420. 
https://www.ncbi.nlm.nih.gov/pubmed/10569436

585.Baker, E.R., et al. Pregnancy in spinal cord injured women. Arch Phys Med Rehabil, 1996. 77: 501. 
https://www.ncbi.nlm.nih.gov/pubmed/8629929

586.Baker, E.R., et al. Risks associated with pregnancy in spinal cord-injured women. Obstet Gynecol, 1992. 80: 425. 
https://www.ncbi.nlm.nih.gov/pubmed/1495699

587.Bertschy, S., et al. Delivering care under uncertainty: Swiss providers’ experiences in caring for women with spinal cord injury during pregnancy and childbirth - an expert interview study. BMC Pregnancy Childbirth, 2016. 16: 181. 
https://www.ncbi.nlm.nih.gov/pubmed/27443838

588.Le Liepvre, H., et al. Pregnancy in spinal cord-injured women, a cohort study of 37 pregnancies in 25 women. Spinal Cord, 2017. 55: 167. 
https://www.ncbi.nlm.nih.gov/pubmed/27670808

589.Skowronski, E., et al. Obstetric management following traumatic tetraplegia: case series and literature review. Aust N Z J Obstet Gynaecol, 2008. 48: 485. 
https://www.ncbi.nlm.nih.gov/pubmed/19032665

590.Cross, L.L., et al. Pregnancy, labor and delivery post spinal cord injury. Paraplegia, 1992. 30: 890. 
https://www.ncbi.nlm.nih.gov/pubmed/1287543

591.Hughes, S.J., et al. Management of the pregnant woman with spinal cord injuries. Br J Obstet Gynaecol, 1991. 98: 513. 
https://www.ncbi.nlm.nih.gov/pubmed/1873238

592.Dannels, A., et al. The perimenopause experience for women with spinal cord injuries. SCI Nurs, 2004. 21: 9. 
https://www.ncbi.nlm.nih.gov/pubmed/15176344

593.Amato, M.P., et al. Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach. Neurol Sci, 2017. 38: 1849. 
https://www.ncbi.nlm.nih.gov/pubmed/28770366

594.Delaney, K.E., et al. Multiple sclerosis and sexual dysfunction: A need for further education and interdisciplinary care. NeuroRehabilitation, 2017. 41: 317. 
https://www.ncbi.nlm.nih.gov/pubmed/29036844

595.Kanagaraj, P., et al. Multiple sclerosis and pregnancy. The Obstetrician & Gynaecologist, 2019. 21: 177. 
https://obgyn.onlinelibrary.wiley.com/journal/17444667

596.Bove, R., et al. Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review. Obstet Gynecol, 2014. 124: 1157. 
https://www.ncbi.nlm.nih.gov/pubmed/25415167

597.Abrams, P., et al. A proposed guideline for the urological management of patients with spinal cord injury. BJU Int, 2008. 101: 989. 
https://www.ncbi.nlm.nih.gov/pubmed/18279449

598.Birkhauser, V., et al. Urodynamics Are Essential to Predict the Risk for Upper Urinary Tract Damage after Acute Spinal Cord Injury. Biomedicines, 2023. 11. 
https://www.ncbi.nlm.nih.gov/pubmed/37371843

599.Beck, J., et al. Clinical Predictors of Neurogenic Lower Urinary Tract Dysfunction in Persons with Multiple Sclerosis. Diagnostics (Basel), 2022. 12. 
https://www.ncbi.nlm.nih.gov/pubmed/35054358

600.Przydacz, M., et al. Recommendations for urological follow-up of patients with neurogenic bladder secondary to spinal cord injury. Int Urol Nephrol, 2018. 50: 1005. 
https://www.ncbi.nlm.nih.gov/pubmed/29569211

601.Hu, Y., et al. A nomogram for predicting neurogenic lower urinary tract dysfunction in patients with acute ischemic stroke: A retrospective study. Neurourol Urodyn, 2024. 43: 2157. 
https://www.ncbi.nlm.nih.gov/pubmed/38962959

602.Wu, X., et al. Prediction of early bladder outcomes after spinal cord injury: The HALT score. CNS Neurosci Ther, 2024. 30: e14628. 
https://www.ncbi.nlm.nih.gov/pubmed/38421138

603.Pannek, J., et al. Clinical usefulness of ultrasound assessment of detrusor wall thickness in patients with neurogenic lower urinary tract dysfunction due to spinal cord injury: urodynamics made easy? World J Urol, 2013. 31: 659. 
https://www.ncbi.nlm.nih.gov/pubmed/23073657

604.Silva, J.A., et al. Association between the bladder wall thickness and urodynamic findings in patients with spinal cord injury. World J Urol, 2015. 33: 131. 
https://www.ncbi.nlm.nih.gov/pubmed/24573904

605.Veenboer, P.W., et al. Diagnostic accuracy of Tc-99m DMSA scintigraphy and renal ultrasonography for detecting renal scarring and relative function in patients with spinal dysraphism. Neurourol Urodyn, 2015. 34: 513. 
https://www.ncbi.nlm.nih.gov/pubmed/24706504

606.Pan, H., et al. Bladder Emptying Strategies, Active Follow-up Adherence and Barriers in Post-Discharge Spinal Cord Injury individuals: A Multiple Center Cross-Sectional Study. Patient Prefer Adherence, 2025. 19: 623. 
https://www.ncbi.nlm.nih.gov/pubmed/40124964

607.Tang, X., et al. Effects of a self-efficacy-centered self-management program on neurogenic bladder after spinal cord injury: A randomized controlled trial. Jpn J Nurs Sci, 2025. 22: e12642. 
https://www.ncbi.nlm.nih.gov/pubmed/39746732

608.Lewis, J., et al. A framework for transitioning patients from pediatric to adult health settings for patients with neurogenic bladder. Neurourol Urodyn, 2017. 36: 973. 
https://www.ncbi.nlm.nih.gov/pubmed/27276694

609.Akyüz, M., et al. Youtube as a Source of Information on Sexual Dysfunction, Neurogenic bladder and Neurogenic bowel after Spinal Cord Injury. Sexuality and Disability, 2023. 41: 593. 
https://www.springer.com/journal/11195